<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Vet Res</journal-id><journal-id journal-id-type="iso-abbrev">BMC Vet Res</journal-id><journal-id journal-id-type="pmc-domain-id">327</journal-id><journal-id journal-id-type="pmc-domain">bmcvetres</journal-id><journal-title-group><journal-title>BMC Veterinary Research</journal-title></journal-title-group><issn pub-type="epub">1746-6148</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11963304</article-id><article-id pub-id-type="pmcid-ver">PMC11963304.1</article-id><article-id pub-id-type="pmcaid">11963304</article-id><article-id pub-id-type="pmcaiid">11963304</article-id><article-id pub-id-type="pmid">40176072</article-id><article-id pub-id-type="doi">10.1186/s12917-025-04635-w</article-id><article-id pub-id-type="publisher-id">4635</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Establishment and application of a qPCR method for differential detection of <italic toggle="yes">Brucella</italic> S2 vaccine strain</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Meng</surname><given-names initials="X">Xianran</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="Z">Zheng</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="Y">Yating</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yu</surname><given-names initials="Y">Yu</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>WaGao</surname></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Wang</surname><given-names initials="W">Wenlong</given-names></name><address><email>wwl.imau@163.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Liu</surname><given-names initials="C">Chunxia</given-names></name><address><email>lcx.imau@163.com</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/015d0jq83</institution-id><institution-id institution-id-type="GRID">grid.411638.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 1756 9607</institution-id><institution>College of Veterinary Medicine, Inner Mongolia Agricultural University, </institution></institution-wrap>Hohhot, Inner Mongolia China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00hgh4525</institution-id><institution-id institution-id-type="GRID">grid.496820.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 8002 2479</institution-id><institution>Hetao College and Inner Mongolia Key Laboratory of Tick-Borne Infectious Diseases, </institution></institution-wrap>Bayannur, Inner Mongolia China </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/015d0jq83</institution-id><institution-id institution-id-type="GRID">grid.411638.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 1756 9607</institution-id><institution>College of Life Science, Inner Mongolia Agricultural University, </institution></institution-wrap>Hohhot, Inner Mongolia China </aff><aff id="Aff4"><label>4</label>Ordos Animal Disease Prevention and Control Center, Ordos, Inner Mongolia China </aff></contrib-group><pub-date pub-type="epub"><day>2</day><month>4</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>21</volume><issue-id pub-id-type="pmc-issue-id">478193</issue-id><elocation-id>238</elocation-id><history><date date-type="received"><day>21</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>28</day><month>2</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>02</day><month>04</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>02</day><month>04</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-04-04 12:25:14.290"><day>04</day><month>04</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="12917_2025_Article_4635.pdf"/><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Brucellosis is one of the most serious zoonotic bacterial diseases in the world. The disease has caused serious harm to people and livestock, hindered the healthy development of the breeding industry, and led to serious economic losses.At present, the prevention and control of this kind of disease is still based on vaccine immunization. However, after the widely used vaccine is inoculated to livestock, there is no widely used differential diagnosis method to distinguish vaccine immune antibodies from natural infection antibodies. Quarantine and purification work is difficult to carry out. In addition, there are few studies using real-time PCR(qPCR) methods in the differential diagnosis of natural virulent strains and vaccine strains of brucellosis.The purpose of this study is to establish a rapid, sensitive and accurate differential diagnosis method for <italic toggle="yes">Brucella</italic> S2 vaccine strain, and to solve the problem of lack of identification of <italic toggle="yes">Brucella</italic> S2 vaccine strain and natural virulent strain in clinical detection.It avoids the killing of some livestock due to the positive antibody of the <italic toggle="yes">Brucella</italic> S2 vaccine strain, and can also identify sick animals from immune herds, reducing the economic losses of farms, and providing certain technical support for the quarantine and purification of epidemic diseases.</p></sec><sec><title>Results</title><p id="Par2">In this study, combined with TaqMan probe-based qPCR technology, specific primers and probes were designed according to the specific deletion genes of the <italic toggle="yes">Brucella</italic> S2 vaccine strain,which could be used as marker genes.The qPCR and duplex qPCR detection methods of <italic toggle="yes">Brucella</italic> were successfully established.The method has good specificity, sensitivity and repeatability, the lowest limit of detection can reach 1&#8201;&#215;&#8201;10<sup>1</sup> copies/&#956;L, the sensitivity is about 100 times higher than that of conventional PCR, and there is no cross-reaction with <italic toggle="yes">Escherichia coli</italic>,<italic toggle="yes">Salmonella</italic>,<italic toggle="yes">streptococcus</italic> and other common strains.The coefficient of variation between groups was less than 0.6%, and the coefficient of variation within groups was less than 0.55%.Subsequently, this method was used to monitor the antibody levels in goat inoculated with different doses of <italic toggle="yes">Brucella</italic> S2 vaccine strain, and the method could also detect the corresponding nucleic acid signals in goat milk samples, and the clinical samples were detected. In summary, this method has good specificity, sensitivity and repeatability, and can be used for the differential diagnosis of clinical brucellosis.</p></sec><sec><title>Conclusions</title><p id="Par3">This study successfully established a duplex qPCR detection method for the differential diagnosis of the <italic toggle="yes">Brucella</italic> S2 vaccine strain. From the establishment of the method to the clinical application of the method, it shows that the method can be used for the differential diagnosis of clinical brucellosis.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s12917-025-04635-w.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>qPCR</kwd><kwd>Duplex&#160;qPCR</kwd><kwd><italic toggle="yes">Brucella</italic> S2&#160;vaccine</kwd><kwd>Sensitivity</kwd><kwd>Specificity</kwd></kwd-group><funding-group><award-group><funding-source><institution>Inner Mongolia Autonomous Region First Class Discipline Research Special Project</institution></funding-source><award-id>YLXKZX-NND-012</award-id><award-id>YLXKZX-NND-012</award-id><award-id>YLXKZX-NND-012</award-id><award-id>YLXKZX-NND-012</award-id><award-id>YLXKZX-NND-012</award-id><award-id>YLXKZX-NND-012</award-id><award-id>YLXKZX-NND-012</award-id><principal-award-recipient><name name-style="western"><surname>Meng</surname><given-names>Xianran</given-names></name><name name-style="western"><surname>Li</surname><given-names>Zheng</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Yating</given-names></name><name name-style="western"><surname>Yu</surname><given-names>Yu</given-names></name><name name-style="western"><surname>WaGao</surname></name><name name-style="western"><surname>Wang</surname><given-names>Wenlong</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Chunxia</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Key technologies of dairy goat germplasm innovation and intensive precision breeding</institution></funding-source><award-id>2021ZD0023</award-id><award-id>2021ZD0023</award-id><award-id>2021ZD0023</award-id><award-id>2021ZD0023</award-id><award-id>2021ZD0023</award-id><award-id>2021ZD0023</award-id><award-id>2021ZD0023</award-id><principal-award-recipient><name name-style="western"><surname>Meng</surname><given-names>Xianran</given-names></name><name name-style="western"><surname>Li</surname><given-names>Zheng</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Yating</given-names></name><name name-style="western"><surname>Yu</surname><given-names>Yu</given-names></name><name name-style="western"><surname>WaGao</surname></name><name name-style="western"><surname>Wang</surname><given-names>Wenlong</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Chunxia</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Comparative genomics study of Brucella virulent strains and vaccine strains and establishment of diagnostic methods</institution></funding-source><award-id>NJZZ19041</award-id><award-id>NJZZ19041</award-id><award-id>NJZZ19041</award-id><award-id>NJZZ19041</award-id><award-id>NJZZ19041</award-id><award-id>NJZZ19041</award-id><award-id>NJZZ19041</award-id><principal-award-recipient><name name-style="western"><surname>Meng</surname><given-names>Xianran</given-names></name><name name-style="western"><surname>Li</surname><given-names>Zheng</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Yating</given-names></name><name name-style="western"><surname>Yu</surname><given-names>Yu</given-names></name><name name-style="western"><surname>WaGao</surname></name><name name-style="western"><surname>Wang</surname><given-names>Wenlong</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Chunxia</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; BioMed Central Ltd., part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par21"><italic toggle="yes">Brucella</italic> is the pathogen of brucellosis. Brucellosis is a global zoonotic disease affecting a wide range of mammals, including livestock and humans [<xref ref-type="bibr" rid="CR1">1</xref>]. In 1905, <italic toggle="yes">Brucella melitensis</italic> was successfully isolated from goat milk in Malta, which proved the zoonotic nature of brucellosis [<xref ref-type="bibr" rid="CR2">2</xref>]. <italic toggle="yes">Brucella</italic> can be transmitted through the digestive tract, respiratory tract and damaged skin mucosa.Humans are usually infected with the disease by contact with diseased livestock, products and contaminants ( such as feces and aborted fetuses).After infection, symptoms such as repeated high fever, fatigue and joint pain can occur.<italic toggle="yes">Brucella</italic> is susceptible to almost all terrestrial animals and mammals in the ocean. Among terrestrial livestock, sheep, cattle and pigs are most susceptible. <italic toggle="yes">Brucella</italic> infection can affect the reproductive system of livestock, such as abortion and orchitis, thus reducing the milk production and dairy quality of livestock, and may even lead to the spread and spread of diseases [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. Compared with male livestock, female livestock are more likely to be infected with brucellosis, and adult livestock are also more likely to be infected than young livestock [<xref ref-type="bibr" rid="CR5">5</xref>]. In marine mammals, <italic toggle="yes">Brucella</italic> can affect the reproductive tract and cause abortion, but this pathogen may also cause fatal complications, including meningoencephalitis, spleen and liver necrosis. Due to the ability of bacteria to spread throughout the body, patients may have symptoms such as liver and spleen enlargement and lymph node enlargement [<xref ref-type="bibr" rid="CR6">6</xref>].</p><p id="Par22">In recent years, due to the widespread epidemic of brucellosis among humans and animals, the annual number of new cases has remained high. Human brucellosis is mostly transmitted through animals.The prevention of human brucellosis depends on the prevention and purification of livestock brucellosis.At present,the main prevention and control measures for brucellosis in China are based on the combination of vaccination and quarantine purification.Vaccines have played an important role in the prevention and control of brucellosis, but they have also brought some new problems.The current serological diagnostic methods are generally used to detect the presence of <italic toggle="yes">Brucella</italic> antibodies,Such as Rose-Bengal plate-agglutination test(RBPT) and tube agglutination test(SAT),etc.But they cannot distinguish vaccine immune antibodies from natural infection antibodies,nor can they distinguish diseased animals from immune groups, which makes it difficult to carry out quarantine and purification work effectively. This is not only a potential threat to humans, but also a danger to fellow animals.so it is of great significance to study the differential diagnosis method of brucellosis. The common <italic toggle="yes">Brucella</italic> vaccines on the market in China include <italic toggle="yes">Brucella suis</italic> S2 vaccine, <italic toggle="yes">Brucella abortus</italic> A19 vaccine and <italic toggle="yes">Brucella melitensis</italic> M5,Rev.1 vaccine,etc. Among them, the <italic toggle="yes">Brucella</italic> S2 vaccine was isolated from the aborted fetus of sows by the China Veterinary Drug Supervision Institute and put into use after weakening.Compared with <italic toggle="yes">Brucella</italic> S19 and <italic toggle="yes">Brucella</italic> Rev.1, <italic toggle="yes">Brucella</italic> S2 has the advantages of low residual virulence, low production cost and relatively easy oral immunization [<xref ref-type="bibr" rid="CR7">7</xref>]. However, after inoculation with <italic toggle="yes">Brucella</italic> S2 vaccine, it will interfere with the diagnosis of brucellosis. Ordinary detection methods cannot distinguish <italic toggle="yes">Brucella</italic> S2 vaccine strain infection from natural virulent strain infection.This also means that it is imperative to develop a diagnostic method for differential diagnosis of <italic toggle="yes">Brucella</italic> S2 vaccine strain infection and natural virulent strain infection.</p><p id="Par23">Real-time PCR can monitor the whole PCR process in real time according to the synchronous accumulation of fluorescence signal and PCR amplification products [<xref ref-type="bibr" rid="CR8">8</xref>]. It has the advantages of high sensitivity, high specificity and short time, and has been widely used in the diagnosis of many pathogens [<xref ref-type="bibr" rid="CR9">9</xref>]. It is divided into two methods: dye method and probe method. Among them, SYBR Green I dye based qPCR method is more likely to form hairpin structure and primer dimer, resulting in false positive results, and the specificity and sensitivity are lower than TaqMan probe method [<xref ref-type="bibr" rid="CR10">10</xref>]. TaqMan-MGB probe was first reported in 2000. MGB stabilizes the A/T-rich double strands, allowing the use of shorter probes and higher melting temperatures than conventional DNA probes, and MGB probes are highly specific,easy to operate, and suitable for most mutations [<xref ref-type="bibr" rid="CR11">11</xref>]. At present, new diagnostic techniques and early screening of newly introduced animals are crucial for the prevention and control of brucellosis.Brucellosis diagnostic techniques include etiological diagnostic techniques,serological diagnostic techniques,and molecular biological diagnostic techniques [<xref ref-type="bibr" rid="CR12">12</xref>]. The methods for the detection of brucellosis have certain limitations,Etiological diagnosis is considered to be the 'gold standard' for the diagnosis of brucellosis.But it has a certain risk.Therefore, etiological diagnosis is not suitable for routine clinical testing [<xref ref-type="bibr" rid="CR13">13</xref>]. The RBPT can be used for the primary screening of brucellosis, with high specificity, low sensitivity and high false negative rate [<xref ref-type="bibr" rid="CR14">14</xref>]. The results of SAT are also affected by human subjective factors, and it takes a long time.Therefore, it is not suitable for large-scale clinical testing [<xref ref-type="bibr" rid="CR15">15</xref>]. Many PCR-based detection methods have been developed, such as conventional PCR based on <italic toggle="yes">Brucella BCSP31 gene</italic> and 16S&#8201;&#177;&#8201;23S rRNA operon, PCR that can identify <italic toggle="yes">Brucella</italic> species,such as AMOS-PCR (based on <italic toggle="yes">IS711</italic>),Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR&#8211;RFLP) (e.g.the <italic toggle="yes">omp2</italic> locus),arbitrary-primed PCR,and ERIC-PCR,Loop-Mediated Isothermal Amplification (LAMP) and so on [<xref ref-type="bibr" rid="CR16">16</xref>]. In 2000, Notomi developed a new molecular detection technology,called LAMP [<xref ref-type="bibr" rid="CR17">17</xref>], Mujiaming designed three sets of primers based on the <italic toggle="yes">Brucella</italic> S2 vaccine strain specific gene <italic toggle="yes">GL_0002189</italic> and <italic toggle="yes">TrbJ</italic> sequences, and five sets of LAMP primers based on the <italic toggle="yes">eryC</italic> gene deletion sequence of <italic toggle="yes">Brucella</italic> S19 vaccine. The results showed that the LAMP method based on the <italic toggle="yes">Brucella</italic> S2 specific gene of <italic toggle="yes">Brucella</italic> could effectively distinguish <italic toggle="yes">Brucella</italic> S2 vaccine strain from <italic toggle="yes">Brucella abortus</italic> and <italic toggle="yes">Brucella melitensis</italic>.The LAMP method established by the specific gene of <italic toggle="yes">Brucella</italic> S19 can effectively distinguish the <italic toggle="yes">Brucella</italic> S19 vaccine strain from the natural virulent strain of <italic toggle="yes">Brucella abortus</italic> and <italic toggle="yes">Brucella melitensis</italic> [<xref ref-type="bibr" rid="CR18">18</xref>]. But its sensitivity is the same as that of conventional PCR.PCR&#8211;RFLP is based on PCR amplification of the target region containing the mutation site of the studied species, followed by restriction enzyme digestion and gel electrophoresis to visualize the RFLP map [<xref ref-type="bibr" rid="CR19">19</xref>]. However, it also needs agarose gel electrophoresis to observe the results after PCR amplification, and there is a risk of contamination.While qPCR can ensure its sensitivity, it can also be monitored in real time. Therefore, it is imperative to study the detection methods that can identify <italic toggle="yes">Brucella</italic> natural infection and vaccine immunized animals in China [<xref ref-type="bibr" rid="CR20">20</xref>].</p></sec><sec id="Sec2"><title>Materials and methods</title><sec id="Sec3"><title>Source of test samples</title><p id="Par24">In the part of identification and detection of <italic toggle="yes">Brucella</italic> S2 vaccine strain by duplex qPCR method, the sample used was a farm in Hohhot, Inner Mongolia. This sample is a goat sample.</p><p id="Par25">In the clinical sample detection part, the sample used was a farm in Bayannur City, Inner Mongolia.This sample is a sheep sample.</p></sec><sec id="Sec4"><title>Screening of differential fragments and PCR amplification</title><sec id="Sec5"><title>Screening of differential fragments</title><p id="Par26">SnapGene software was used to compare the whole genome sequences of the <italic toggle="yes">Brucella</italic> S2 vaccine strain and <italic toggle="yes">Brucella suis</italic> natural virulent strain 1330, and the differential sequences between the two strains were screened. Then the differential sequences were compared with other <italic toggle="yes">Brucella</italic> strains to find out the specific gene fragments with certain coverage and can distinguish <italic toggle="yes">Brucella</italic> S2 vaccine strain from other <italic toggle="yes">Brucella</italic> strains as candidate molecular target genes for differential detection. Then the differential fragments were compared with other <italic toggle="yes">Brucella</italic> strains by BLAST function on the NCBI website, and the differential sequences with certain coverage and specificity were screened out. Primers were designed according to the gene sequence information of the specific deletion site of the <italic toggle="yes">Brucella</italic> S2 vaccine strain.</p></sec><sec id="Sec6"><title>PCR amplification</title><p id="Par27">Primers were designed according to the gene sequence information of the specific deletion site of the <italic toggle="yes">Brucella</italic> S2 vaccine strain (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>).
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>3 pairs of primer sequence information</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Primer pair number</th><th align="left" colspan="1" rowspan="1">sequence</th><th align="left" colspan="1" rowspan="1">Purpose fragment length</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">1</td><td align="left" colspan="1" rowspan="1">F: AAACCGACGACGCAGGAC</td><td align="left" rowspan="2" colspan="1">193 bp</td></tr><tr><td align="left" colspan="1" rowspan="1">R: CGAGATAACCCAGATTGACC</td></tr><tr><td align="left" rowspan="2" colspan="1">2</td><td align="left" colspan="1" rowspan="1">F: CGCTGGGCAATCAGGAAC</td><td align="left" rowspan="2" colspan="1">134 bp</td></tr><tr><td align="left" colspan="1" rowspan="1">R: CGCTGGACCGATACGATAA</td></tr><tr><td align="left" rowspan="2" colspan="1">3</td><td align="left" colspan="1" rowspan="1">F: ATATTGCGCAGCTTCACACC</td><td align="left" rowspan="2" colspan="1">133 bp</td></tr><tr><td align="left" colspan="1" rowspan="1">R: CATCATAGTCGAGATAACCCAGATTG</td></tr></tbody></table></table-wrap></p><p id="Par28">As the nucleic acid identification sequence for screening is the common difference between <italic toggle="yes">Brucella</italic> S2 attenuated vaccine and other types of <italic toggle="yes">Brucella</italic> (including common <italic toggle="yes">Brucella</italic> attenuated vaccine strains and natural strong strains), the whole genome DNA of <italic toggle="yes">Brucella</italic> A19 attenuated vaccine strain and <italic toggle="yes">Brucella</italic> S2 attenuated vaccine strain was used as a template to carry out PCR amplification and sequencing of nucleic acid marker sequence genes for genetic difference verification.The whole genome DNA of <italic toggle="yes">Brucella</italic> A19 attenuated vaccine strain and <italic toggle="yes">Brucella</italic> S2 attenuated vaccine strain was used as a template to carry out PCR amplification and sequencing of nucleic acid marker sequence genes for genetic difference verification.The reaction system is shown in Supplementary File 5.</p></sec></sec><sec id="Sec7"><title>Establishment of two qPCR detection methods for <italic toggle="yes">Brucella</italic></title><p id="Par29">TaqMan probe-based qPCR is a nucleic acid quantitative technology developed on the basis of PCR qualitative technology, which has been widely used in nucleic acid detection and quantification [<xref ref-type="bibr" rid="CR21">21</xref>]. It has the advantages of high sensitivity, strong specificity, direct detection of viral nucleic acid and quantitative detection of nucleic acid concentration [<xref ref-type="bibr" rid="CR22">22</xref>]. And high-throughput TaqMan probe genotyping method has been used to detect single nucleotide polymorphism ( SNP) [<xref ref-type="bibr" rid="CR23">23</xref>]. In order to develop a new molecular diagnostic method, this study carried out TaqMan probe-based qPCR detection method research based on the specific deletion site of the <italic toggle="yes">Brucella</italic> S2 vaccine strain, in order to provide a new choice for qPCR nucleic acid detection of <italic toggle="yes">Brucella</italic>.</p><sec id="Sec8"><title>Design and synthesis of qPCR probe</title><p id="Par30">Primer Express 3.0 was used to design the probe. After the target fragment was introduced, the Tm value of the probe was about 10&#160;&#176;C higher than that of the primer. Two S2-HEX probes and one NS2-ROX probe were designed and synthesized (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>).
<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Screened primer and probe sequences</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Gene name</th><th align="left" colspan="1" rowspan="1">Sequence</th><th align="left" colspan="1" rowspan="1">Tm value</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">primer(193 bp)</td><td align="left" rowspan="2" colspan="1"><p>F: AAACCGACGACGCAGGAC</p><p>R: CGAGATAACCCAGATTGACC</p></td><td align="left" colspan="1" rowspan="1">58.2 &#8451;</td></tr><tr><td align="left" colspan="1" rowspan="1">53.2 &#8451;</td></tr><tr><td align="left" colspan="1" rowspan="1">S2-HEX-1probe</td><td align="left" colspan="1" rowspan="1">TGATCGGACGGTCTC</td><td align="left" colspan="1" rowspan="1">69.0 &#8451;</td></tr><tr><td align="left" colspan="1" rowspan="1">S2-HEX-2probe</td><td align="left" colspan="1" rowspan="1">GAGACCGTCCGATCA</td><td align="left" colspan="1" rowspan="1">71.0 &#8451;</td></tr><tr><td align="left" colspan="1" rowspan="1">NS2-ROXprobe</td><td align="left" colspan="1" rowspan="1">TTGATCGGACGGGTCT</td><td align="left" colspan="1" rowspan="1">70.0 &#8451;</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec9"><title>Preparation of recombinant plasmid standard</title><p id="Par31">Construction of <italic toggle="yes">Brucella</italic> S2 and <italic toggle="yes">Brucella</italic> A19 recombinant plasmid standards: The target fragment was amplified according to the designed primers. The PCR reaction procedure was: 95&#160;&#176;C 5&#160;min, 95&#160;&#176;C 50&#160;s, 60&#160;&#176;C 50&#160;s, 72&#160;&#176;C 30&#160;s, 30 cycles, 72&#160;&#176;C extension 10&#160;min. The PCR reaction system is shown in Supplementary File 6.Subsequently, the gel recovery and cloning expression were carried out, and a single colony was selected for culture 3 &#956;L bacterial solution was used as the template for PCR amplification, and a negative control was set up. The PCR reaction procedure was the same as above. The reaction system of bacterial solution PCR is shown in Supplementary File 7.Finally, 2&#160;mL bacterial solution was taken to extract the plasmid, and the plasmid concentration was measured by NanoDrop nucleic acid concentration meter. According to the formula: copy number&#8201;=&#8201;( 6.02&#8201;&#215;&#8201;10<sup>23</sup>&#8201;&#215;&#8201;concentration&#8201;&#215;&#8201;10<sup>&#8211;9</sup>) / [ ( clone vector length&#8201;+&#8201;product size)&#8201;&#215;&#8201;660] unit converted to copies / &#956;L, and the initial concentration of the two plasmids was adjusted to 1&#8201;&#215;&#8201;10<sup>9</sup> copies / &#956;L.</p></sec><sec id="Sec10"><title>Optimization of qPCR reaction conditions</title><p id="Par32">The primer and probe are diluted to a working concentration of 10&#160;&#956;mol/L, and the reaction system is shown in Supplementary File 8, the reaction procedure is shown in the Table&#160;<xref rid="Tab3" ref-type="table">3</xref>. Keeping the reaction program unchanged, primers and probes were added on the basis of 10&#160;&#956;mol / L, and the addition amount was set to 0.2 &#956;L, 0.4 &#956;L, 0.6 &#956;L, 0.8 &#956;L, and 1 &#956;L. The reaction system was optimized by the checkerboard method to determine the optimal primer and probe addition amount. Finally, the primer and probe addition amount with the lowest Ct value under the same concentration of positive template was the best reaction amount.
<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p>The reaction procedure of qPCR</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">reaction stage</th><th align="left" colspan="1" rowspan="1">Reaction temperature</th><th align="left" colspan="1" rowspan="1">reaction time</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Pre-denaturation</td><td align="left" colspan="1" rowspan="1">95&#8451;</td><td align="left" colspan="1" rowspan="1">30s</td></tr><tr><td align="left" rowspan="2" colspan="1">PCR amplification</td><td align="left" colspan="1" rowspan="1">95&#8451;</td><td align="left" colspan="1" rowspan="1">5s</td></tr><tr><td align="left" colspan="1" rowspan="1">60&#8451;</td><td align="left" colspan="1" rowspan="1">30s</td></tr><tr><td align="left" colspan="3" rowspan="1">Number of 40 cycles</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec11"><title>Establishment of standard curve</title><p id="Par33">The concentrations of <italic toggle="yes">Brucella</italic> A19 and <italic toggle="yes">Brucella</italic> S2 recombinant plasmids were diluted to 1&#8201;&#215;&#8201;10<sup>8</sup> copies / &#956;L, 1&#8201;&#215;&#8201;10<sup>7</sup> copies / &#956;L, 1&#8201;&#215;&#8201;10<sup>6</sup> copies / &#956;L, 1&#8201;&#215;&#8201;10<sup>5</sup> copies / &#956;L, 1&#8201;&#215;&#8201;10<sup>4</sup> copies / &#956;L by DNA Dilution Buffer, respectively. The recombinant plasmid was used as a template, and three replicates were made for each dilution. The initial dilution concentration was set to 1.00E&#8201;+&#8201;04 ( corresponding to the template concentration). Two qPCR amplification curves were obtained for <italic toggle="yes">Brucella</italic> S2 and <italic toggle="yes">Brucella</italic> A19 vaccine sequences using the optimized reaction system.</p></sec><sec id="Sec12"><title>Specificity experiment</title><p id="Par34">The <italic toggle="yes">Beucella</italic> S2 vaccine strain DNA was used as the positive control, the genomic DNA extracted from <italic toggle="yes">Escherichia coli,Salmonella,Pediococcus acidilactici</italic> and <italic toggle="yes">Streptococcus</italic> was used as the template of the reaction group, and the RNase-free Water was used as the negative control group. Each group was set up three holes to observe whether the qPCR reaction had amplification curve and to evaluate whether the detection method was specific.</p></sec><sec id="Sec13"><title>Sensitivity experiment</title><p id="Par35">The two recombinant plasmids were diluted 10 times from 10<sup>5</sup> copies / &#956;L to 10<sup>1</sup> copies/&#956;L, and the diluted recombinant plasmid was used as a template.Three replicate wells were set for each concentration gradient of the two qPCR reactions, and RNase-free Water was used as a negative control to evaluate the sensitivity of the two qPCR reactions.The two recombinant plasmids were diluted from 10<sup>6</sup> copies / &#956;L to 10<sup>1</sup> copies / &#956;L, and the diluted recombinant plasmids were used as templates for conventional PCR. The sensitivity of qPCR and conventional PCR was compared.</p></sec><sec id="Sec14"><title>Repeatability experiment</title><p id="Par36">The concentration of each recombinant plasmid was 1&#8201;&#215;&#8201;10<sup>6</sup> copies/&#956;L, 1&#8201;&#215;&#8201;10<sup>5</sup> copies/&#956;L, and 1&#8201;&#215;&#8201;10<sup>4</sup> copies/&#956;L respectively as positive templates. The optimized single reaction condition. After replacing different batches of Premix Ex Taq ( Probe qPCR), the experiment was repeated again. The coefficient of variation of Ct values within and between groups was calculated to evaluate the repeatability of single qPCR.</p></sec></sec><sec id="Sec15"><title>Establishment of duplex qPCR differential diagnosis method for <italic toggle="yes">Brucella </italic>S2 vaccine strain</title><p id="Par37">Two probes were added to the reaction system at the same time to optimize the duplex qPCR reaction system and reduce the mutual interference between primers and probes to obtain a stable and reliable duplex qPCR differential diagnosis method, and realize the purpose of differential diagnosis of <italic toggle="yes">Brucella</italic> S2 vaccine strain and natural virulent strain by single tube qPCR.</p><sec id="Sec16"><title>Optimization of duplex qPCR reaction conditions</title><p id="Par38">The reaction system was optimized by the checkerboard method. The qPCR reaction conditions and the concentration of the two primers and probes were fixed at 10&#160;&#956;mol/L, and the upstream and downstream primers and probes of the duplex qPCR reaction systems of S2-HEX and NS2-ROX were adjusted respectively.12.5&#956;L Premix Ex Taq ( Probe qPCR) was added to the 25&#956;L reaction system, and the amount of primers was adjusted to 0.2&#956;L, 0.4&#956;L, 0.6&#956;L, 0.8&#956;L and 1.0&#956;L, respectively, to optimize the amount of primers. The volumes of the two probes ( S2 probe and NS2 probe) were adjusted to 0.2&#956;L, 0.4&#956;L, 0.6&#956;L, 0.8&#956;L, and 1.0&#956;L, respectively, to optimize the probe amount. At the same template concentration, the reaction amount with the smallest Ct value is the best reaction amount.</p></sec><sec id="Sec17"><title>Establish standard curve</title><p id="Par39">The concentration of the two recombinant plasmids was adjusted to 1&#8201;&#215;&#8201;10<sup>9</sup> copies / &#956;L, and then mixed in equal proportion. After 10 times of equal proportion dilution, the mixed standard recombinant plasmids of 1&#8201;&#215;&#8201;10<sup>9</sup> copies / &#956;L, 1&#8201;&#215;&#8201;10<sup>8</sup> copies / &#956;L, 1&#8201;&#215;&#8201;10<sup>7</sup> copies / &#956;L, 1&#8201;&#215;&#8201;10<sup>6</sup> copies / &#956;L, 1&#8201;&#215;&#8201;10<sup>5</sup> copies / &#956;L and 1&#8201;&#215;&#8201;10<sup>4</sup> copies / &#956;L were obtained after dilution. Two mixed plasmids were used as templates, and 2 &#956;L was added to each well. In addition, RNase-free Water was used as the negative control group, and each concentration was repeated three times. The target fragment amplification and fluorescence signal detection were performed with the optimized reaction system and reaction procedure, and the standard curve of duplex qPCR amplification was obtained.</p></sec><sec id="Sec18"><title>Specificity experiment and evaluation of identification effect</title><p id="Par40">Two standard positive mixed plasmids were used as the positive control group, and RNase-free Water was used as the negative control group. DNA of <italic toggle="yes">Brucella</italic> A19 vaccine strain, DNA of <italic toggle="yes">Brucella</italic> S2 vaccine strain, DNA of <italic toggle="yes">Brucella</italic> Rev.1 vaccine strain and genomic DNA extracted from <italic toggle="yes">Escherichia coli</italic>,<italic toggle="yes">Salmonella,Pediococcus acidilactici</italic> and <italic toggle="yes">Streptococcus</italic> were used as templates, respectively. Three replicate wells were made for each template, and the specificity and identification effect of the established duplex qPCR detection method were evaluated.</p></sec><sec id="Sec19"><title>Sensitivity experiment</title><p id="Par41">Two kinds of 1&#8201;&#215;&#8201;10<sup>9</sup> copies / &#956;L standard positive recombinant plasmids were mixed in equal proportion, and then ten-fold gradient diluted to 1&#8201;&#215;&#8201;10<sup>9</sup>&#8201;~&#8201;1&#8201;&#215;&#8201;10<sup>1</sup> copies / &#956;L, a total of 9 concentrations of double mixed standard positive plasmids. The mixed recombinant plasmids of 5 concentrations of 1&#8201;&#215;&#8201;10<sup>5</sup>&#8201;~&#8201;1&#8201;&#215;&#8201;10<sup>1</sup> copies / &#956;L with ten-fold gradient dilution were selected as templates.Each concentration gradient is set to 3 multiple holes, and RNase-free Water was used as a negative control to evaluate the sensitivity of the duplex qPCR reaction. Six mixed recombinant plasmids with a concentration of 1&#8201;&#215;&#8201;10<sup>6</sup>&#8201;~&#8201;1&#8201;&#215;&#8201;10<sup>1</sup> copies / &#956;L were selected, and ten-fold gradient dilution was used as a template.The negative control group with RNase-free Water as a template was subjected to conventional PCR. The sensitivity of duplex q PCR and conventional PCR was compared.</p></sec><sec id="Sec20"><title>Repeatability experiment</title><p id="Par42">Two equal proportion mixed plasmids with three concentrations of 1&#8201;&#215;&#8201;10<sup>6</sup> copies / &#956;L, 1&#8201;&#215;&#8201;10<sup>5</sup> copies / &#956;L and 1&#8201;&#215;&#8201;10<sup>4</sup> copies / &#956;L were selected as templates, and each concentration was repeated three times. After 7&#160;days, the experiment was repeated again. After 21&#160;days, different batches of Premix Ex Taq ( Probe qPCR) repeated experiments were replaced to evaluate the repeatability of this method.</p></sec></sec><sec id="Sec21"><title>Application of duplex qPCR method for differential detection of <italic toggle="yes">Brucella</italic> S2 vaccine strain</title><sec id="Sec22"><title>Study on the bacterial retention of <italic toggle="yes">Brucella</italic> S2 vaccine in the whole blood of dairy goats</title><p id="Par43">Thirty goat were divided into three groups, 10 goat in the recommended dose group, 10 goat in the double dose group and 10 goat in the negative control group. Blood samples were collected before immunization and 3,5,7,15,21,30,60,90,120,150,180,210 and 240&#160;days after immunization. The serum was separated and detected by RBPT, SAT and iELISA.After the nucleic acid was extracted from the whole blood, the <italic toggle="yes">Brucella</italic> S2 vaccine antibody or other vaccine strain and natural strain antibody were detected by the established <italic toggle="yes">Brucella</italic> S2 vaccine strain duplex qPCR differential diagnosis method. It can not only verify the sensitivity of this research method, but also provide a reference for the dose and time of <italic toggle="yes">Brucella</italic> S2 vaccine inoculation in dairy goats.</p><sec id="FPar1"><title>Rose-Bengal plate-agglutination test and tube agglutination test</title><p id="Par44">The non-anticoagulant blood collected at different time points was placed in a refrigerator at 4&#160;&#176;C overnight, and the serum was separated the next day.</p><p>Rose-Bengal plate-agglutination test: After the Rose-Bengal plate-agglutination test antigen was balanced to room temperature, the Rose-Bengal plate-agglutination test was performed. The results were observed within 4&#160;min. At the same time, standard negative serum and standard positive serum were set as controls. When the standard negative serum did not agglutinate and the standard positive serum agglutinated, the serum to be tested could be determined.</p><p>Tube agglutination test: 0.5% carbonic acid solution was prepared before the test, and 121&#160;&#176;C high pressure for 30&#160;min. The turbidity tube was prepared according to Table&#160;<xref rid="Tab4" ref-type="table">4</xref>, and the standard negative and positive controls were set up. Finally, the added test tube was placed in a constant temperature and humidity incubator at 37&#176; C for 18&#8211;24&#160;h, and the results were observed and recorded.
<table-wrap id="Tab4" position="float" orientation="portrait"><label>Table 4</label><caption><p>Turbidity tube configuration</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Pipe number</th><th align="left" colspan="1" rowspan="1">Diluted antigen solution/&#956;L</th><th align="left" colspan="1" rowspan="1">0.5% carbolic acid solution/&#956;L</th><th align="left" colspan="1" rowspan="1">Brightness / %</th><th align="left" colspan="1" rowspan="1">label</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">1000</td><td align="left" colspan="1" rowspan="1">100</td><td align="left" colspan="1" rowspan="1">&#8201;+&#8201;&#8201;+&#8201;&#8201;+&#8201;&#8201;+&#8201;</td></tr><tr><td align="left" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">250</td><td align="left" colspan="1" rowspan="1">750</td><td align="left" colspan="1" rowspan="1">75</td><td align="left" colspan="1" rowspan="1">&#8201;+&#8201;&#8201;+&#8201;&#8201;+&#8201;</td></tr><tr><td align="left" colspan="1" rowspan="1">3</td><td align="left" colspan="1" rowspan="1">500</td><td align="left" colspan="1" rowspan="1">500</td><td align="left" colspan="1" rowspan="1">50</td><td align="left" colspan="1" rowspan="1">&#8201;+&#8201;&#8201;+&#8201;</td></tr><tr><td align="left" colspan="1" rowspan="1">4</td><td align="left" colspan="1" rowspan="1">750</td><td align="left" colspan="1" rowspan="1">250</td><td align="left" colspan="1" rowspan="1">25</td><td align="left" colspan="1" rowspan="1">&#8201;+&#8201;</td></tr><tr><td align="left" colspan="1" rowspan="1">5</td><td align="left" colspan="1" rowspan="1">1000</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr></tbody></table></table-wrap></p></sec><sec id="FPar2"><title>Brucellosis kit antibody detection</title><p id="Par47">The packaged serum was ablated and thawed, and 2 negative control holes and 2 positive control holes were set up in each plate, and 50 &#956;L was added to each hole. Then 50 &#956;L of serum sample was added to the remaining wells, and 100 &#956;L of horseradish peroxidase-labeled detection antibody was added to the control wells and sample wells, and incubated at 37&#176; C for 60&#160;min. After drying time, each hole was filled with 350 &#956;L of detergent. After standing for 1&#160;min, the detergent was removed and the absorbent paper was dried. Wash the board 5 times. After that, 50 &#956;L of substrates A and B were added to each well and incubated in the dark at 37&#160;&#176;C for 15&#160;min. Finally, 50 &#956;L termination solution was added to each hole. After the above operation is completed, as soon as possible with microplate reader detection, measurement of absorbance ( OD value), with reference to the instructions, the negative control OD value&#8201;+&#8201;0.25, the sample OD value is greater than the threshold, determined as positive, otherwise negative.</p></sec><sec id="FPar3"><title>Extraction and detection of genomic DNA from whole blood of <italic toggle="yes">Brucella</italic></title><p id="Par48">Thirty whole blood samples were collected at different time points. The red blood cell lysis method was used to operate according to the instructions of the blood genomic DNA extraction kit. Firstly, 900 &#956;L of red blood cell lysis solution was added to 300 &#956;L of blood for sample pretreatment. Finally, 50 &#956;L of TE elution buffer was used to elute DNA, which was packaged in a PCR tube and frozen at-20&#160;&#176;C for subsequent use. The extracted whole blood genomic DNA at different time points was detected by the established duplex qPCR differential diagnosis method of <italic toggle="yes">Brucella</italic>. When the amplification results had a typical amplification curve and the Ct value&#8201;&#8804;&#8201;35, the results were judged to be positive.</p></sec></sec><sec id="Sec24"><title>Study on the bacterial residence of <italic toggle="yes">Brucella</italic> S2 vaccine in dairy goat milk after immunization</title><p id="Par49">Ten goat milk samples with positive <italic toggle="yes">Brucella</italic> antibody and ten goat milk samples with negative <italic toggle="yes">Brucella</italic> antibody were selected. The established duplex qPCR detection method of the <italic toggle="yes">Brucella</italic> S2 vaccine strain was used to detect whether the milk contained <italic toggle="yes">Brucella</italic> S2 vaccine or other vaccines and natural virulent strain nucleic acids. The detection of bacterial residence in dairy goat milk, it can provide a reference for timely screening of <italic toggle="yes">Brucella</italic>-infected goat milk samples, solving the problem of artificial harm caused by live bacteria discharged from goat milk, and providing a reference for the prevention of brucellosis.</p><sec id="FPar4"><title>Extraction of <italic toggle="yes">Brucella</italic> genomic DNA from goat milk</title><p id="Par50">The collected 20 portions of goat milk were operated according to the instructions of the bacterial genomic DNA extraction kit. 1000 &#956;L of goat milk was centrifuged at 10,000 r / min for 1&#160;min for pretreatment. Finally, 50&#956;L of TE elution buffer was used to elute the DNA,which was packaged in a PCR tube and frozen at-20&#160;&#176;C for subsequent use.</p></sec><sec id="FPar5"><title>Sample detection</title><p id="Par51">The 20 goat milk genomic DNA extracted above was detected by the established duplex qPCR differential diagnosis method of the <italic toggle="yes">Brucella</italic> S2 vaccine strain. When the amplification result had a typical amplification curve and the Ct value was&#8201;&#8804;&#8201;35, the result was positive.</p></sec></sec></sec></sec><sec id="Sec25"><title>Results</title><sec id="Sec26"><title>PCR amplification and recombinant plasmid preparation results</title><p id="Par52">After PCR reaction, 1% agarose gel electrophoresis was used for detection.The results are shown in Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>. The PCR products were recovered and sequenced.<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>PCR primer specificity experiment.M,DL500 DNA Marker,lane 1,negative control;lane 2,Primer S2-1;lane 3,Primer S2-2;lane 4,Primer S2-3;lane 5,A19-1;lane 6,A19-2;lane 7,A19-3</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="12917_2025_4635_Fig1_HTML.jpg"/></fig></p><p id="Par53">The pMD-S2 and pMD-NS2 recombinant plasmids were constructed respectively, and the recombinant bacterial liquid was identified by bacterial liquid PCR. The results are shown in Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>, and the sizes of the two target bands are consistent with the expected results. The recombinant bacterial liquid was sequenced and identified. The sequencing results showed that the recombinant bacterial liquid was consistent with the original gene sequence after sequencing, and the homology was 100%. The recombinant plasmid was successfully constructed.<fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><p>Identification of recombination plasmid by PCR.M DL 500 DNA Marker,lane 1,negative control;lane 2, positive control;lane 3,Primer pMD-S2;lane 4,Primer pMD-NS2</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO2" position="float" orientation="portrait" xlink:href="12917_2025_4635_Fig2_HTML.jpg"/></fig></p></sec><sec id="Sec27"><title>Single qPCR optimization results</title><sec id="Sec28"><title>The optimization results of qPCR reaction conditions</title><p id="Par54">In the qPCR reaction, the concentration of the primer&#8211;probe was fixed at 10&#160;&#956;mol / L, and the amount of the primer&#8211;probe was optimized. It was concluded that both S2-HEX and NS2-ROX showed the best amplification curve when the primer amount was 0.8 &#956;L (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>). When the amount of fixed primer was 0.8&#956;L, the amplification curve showed that the optimal amplification curve of S2-HEX appeared when the amount of probe was 1.0&#956;L, and the optimal amplification curve of NS2-ROX appeared when the amount of probe was 0.8&#956;L (Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>).<fig id="Fig3" position="float" orientation="portrait"><label>Fig. 3</label><caption><p>Two single qPCR primer concentration optimization results.The left figure shows the optimization results of S2-HEX primer concentration: the amount of primers was 0.2&#956;L,0.4&#956;L,0.6&#956;L,0.8&#956;L and 1.0&#956;L, respectively.The right figure is the optimization result of NS2-ROX primer concentration: the amount of primers was 0.2&#956;L,0.4&#956;L,0.6&#956;L,0.8&#956;L and 1.0&#956;L, respectively</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO3" position="float" orientation="portrait" xlink:href="12917_2025_4635_Fig3_HTML.jpg"/></fig><fig id="Fig4" position="float" orientation="portrait"><label>Fig. 4</label><caption><p>Two single qPCR probe concentration optimization results.The left image shows the optimization results of S2-HEX probe concentration: the amount of probe was 0.2&#956;L,0.4&#956;L,0.6&#956;L,0.8&#956;L and 1.0&#956;L, respectively. The figure on the right is the optimization result of NS2-ROX probe concentration: the amount of probe was 0.2&#956;L,0.4&#956;L,0.6&#956;L,0.8&#956;L and 1.0&#956;L, respectively</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO4" position="float" orientation="portrait" xlink:href="12917_2025_4635_Fig4_HTML.jpg"/></fig></p></sec><sec id="Sec29"><title>Establishment of standard curve</title><p id="Par55">The recombinant plasmids pMD-S2 and pMD-A19 of 1&#8201;&#215;&#8201;10<sup>9</sup>copies / &#956;L, 1&#8201;&#215;&#8201;10<sup>8</sup>copies / &#956;L, 1&#8201;&#215;&#8201;10<sup>7</sup>copies / &#956;L, 1&#8201;&#215;&#8201;10<sup>6</sup>copies / &#956;L, 1&#8201;&#215;&#8201;10<sup>5</sup>copies / &#956;L and 1&#8201;&#215;&#8201;10<sup>4</sup>copies / &#956;L were used as templates to construct qPCR standard curve with optimized reaction conditions. The amplification efficiency of S2-HEX standard curve was 103.1%, and R<sup>2</sup> was 0.998. The amplification efficiency of NS2-ROX standard curve was 103.6%, and R<sup>2</sup> was 0.998. The values are within the effective range and can be used for subsequent quantitative detection. The standard curve is shown in Fig.&#160;<xref rid="Fig5" ref-type="fig">5</xref>.<fig id="Fig5" position="float" orientation="portrait"><label>Fig. 5</label><caption><p>Results of establishment of standard curves of two single qPCR.The amplification efficiency of S2-HEX standard curve was 103.1%, and R<sup>2</sup> was 0.998. The amplification efficiency of NS2-ROX standard curve was 103.6%, and R.<sup>2</sup> was 0.998</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO5" position="float" orientation="portrait" xlink:href="12917_2025_4635_Fig5_HTML.jpg"/></fig></p></sec><sec id="Sec30"><title>Results of specificity experiment</title><p id="Par56">The DNA of <italic toggle="yes">Brucella</italic> A19 vaccine strain, <italic toggle="yes">Brucella</italic> Rev.1 vaccine strain, <italic toggle="yes">Brucella</italic> S2 vaccine strain and common <italic toggle="yes">Escherichia coli</italic>, <italic toggle="yes">Salmonella</italic>, <italic toggle="yes">Streptococcus</italic>, and <italic toggle="yes">Pediococcus acidilactici</italic> DNA were used as templates for qPCR amplification to verify the specificity of qPCR. The results showed that the positive amplification curve appeared only when the <italic toggle="yes">Brucella</italic> S2 vaccine strain DNA was used as the amplification template in the S2-HEX group. In NS2-ROX group, the positive amplification curve appeared when <italic toggle="yes">Brucella</italic> A19 vaccine strain and <italic toggle="yes">Brucella</italic> Rev.1 vaccine strain were used as amplification templates. There was no amplification curve in the negative control of the two primer probes, and there was no cross reaction with <italic toggle="yes">Escherichia coli</italic>, <italic toggle="yes">Salmonella</italic>, <italic toggle="yes">Streptococcus</italic> and <italic toggle="yes">Pediococcus acidilactici</italic>. The specificity results are shown in Fig.&#160;<xref rid="Fig6" ref-type="fig">6</xref>.<fig id="Fig6" position="float" orientation="portrait"><label>Fig. 6</label><caption><p>Results of specificity of two single qPCR.1,<italic toggle="yes">Brucella</italic> S2 vaccine strain DNA;2,<italic toggle="yes">Brucella</italic> A19 vaccine strain DNA;3,<italic toggle="yes">Brucella</italic> Rev.1 vaccine strain DNA;4&#8211;7,<italic toggle="yes">Escherichia coli</italic> DNA, <italic toggle="yes">Salmonella</italic> DNA, <italic toggle="yes">Pediococcus acidilactici</italic> DNA, <italic toggle="yes">Streptococcus</italic> DNA;8, Negative control</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO6" position="float" orientation="portrait" xlink:href="12917_2025_4635_Fig6_HTML.jpg"/></fig></p></sec><sec id="Sec31"><title>Sensitivity experiment</title><p id="Par57">The results of sensitivity test showed that the amplification curves of S2-HEX and NS2-ROX groups showed that the amplification curves were generated in each multiple hole at 10<sup>5</sup>&#8201;~&#8201;10<sup>1</sup> copies / &#956;L, and S2-HEX had two holes in three parallel holes with 10<sup>1</sup> copies / &#956;L template concentration to produce effective results ( Ct&#8201;&#8804;&#8201;35). NS2-ROX can produce effective results ( Ct&#8201;&#8804;&#8201;35) in three parallel holes with a template concentration of 10<sup>1</sup> copies / &#956;L. The sensitivity test results are shown in Fig.&#160;<xref rid="Fig7" ref-type="fig">7</xref>.<fig id="Fig7" position="float" orientation="portrait"><label>Fig. 7</label><caption><p>Results of sensitivity experiment of two single qPCR.The left figure shows the sensitivity results of S2-HEX: The template concentrations were 10<sup>5</sup>&#8211;10<sup>1</sup> copies/&#956;L, respectively.The right figure shows the sensitivity results of NS2-ROX:The template concentrations were 10<sup>5</sup>&#8211;10<sup>1</sup> copies/&#956;L, respectively</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO7" position="float" orientation="portrait" xlink:href="12917_2025_4635_Fig7_HTML.jpg"/></fig></p><p id="Par58">The primers were amplified by conventional PCR with the same template concentration, and the sensitivity was detected by gel electrophoresis. The results showed that the minimum limit of detection of S2 and NS2 was 1&#8201;&#215;&#8201;10<sup>3</sup> copies / &#956;L, and the sensitivity of the qPCR method was higher than that of conventional PCR about 100 times, the electrophoresis results are shown in Fig.&#160;<xref rid="Fig8" ref-type="fig">8</xref>.<fig id="Fig8" position="float" orientation="portrait"><label>Fig. 8</label><caption><p>Results of sensitivity experiment of PCR.M<bold>,</bold>DL 2000 DNA Marker, <bold>A</bold> lane 1, negative control,lane2,DNA positive control of S2 vaccine strain,3&#8201;~&#8201;8,S2 template concentration1&#8201;&#215;&#8201;10<sup>6</sup> copies/&#956;L&#12289;1&#8201;&#215;&#8201;10<sup>5</sup> copies/&#956;L&#12289;1&#8201;&#215;&#8201;10<sup>4</sup> copies/&#956;L&#12289;1&#8201;&#215;&#8201;10<sup>3</sup> copies/&#956;L&#12289;1&#8201;&#215;&#8201;10<sup>2</sup> copies/&#956;L&#12289;1&#8201;&#215;&#8201;10<sup>1</sup> copies/&#956;L; <bold>B</bold> lane 1, negative control<bold>,</bold>lane <bold>2',</bold>A19 vaccine strain positive control,3&#8201;~&#8201;8, A19 template concentration1&#8201;&#215;&#8201;10<sup>6</sup> copies/&#956;L&#12289;1&#8201;&#215;&#8201;10<sup>5</sup> copies/&#956;L&#12289;1&#8201;&#215;&#8201;10<sup>4</sup> copies/&#956;L&#12289;1&#8201;&#215;&#8201;10<sup>3</sup> copies/&#956;L&#12289;1&#8201;&#215;&#8201;10<sup>2</sup> copies/&#956;L&#12289;1&#8201;&#215;&#8201;10<sup>1</sup> copies/&#956;L</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO8" position="float" orientation="portrait" xlink:href="12917_2025_4635_Fig8_HTML.jpg"/></fig></p></sec><sec id="Sec32"><title>Results of repetitive experiments</title><p id="Par59">The recombinant plasmids of 1&#8201;&#215;&#8201;10<sup>6</sup> copies / &#956;L, 1&#8201;&#215;&#8201;10<sup>5</sup> copies / &#956;L and 1&#8201;&#215;&#8201;10<sup>4</sup> copies / &#956;L were used as templates, and different batches of Premix Ex Taq ( Probe qPCR) were used for repeated experiments. The results showed that the coefficient of variation of the two single qPCR groups was about 0.5%, and the coefficient of variation between groups was less than 0.6%. The amplification curve is shown in Fig.&#160;<xref rid="Fig9" ref-type="fig">9</xref>. Repeated experimental data are shown in Table&#160;<xref rid="Tab5" ref-type="table">5</xref>.<fig id="Fig9" position="float" orientation="portrait"><label>Fig. 9</label><caption><p>Results of repeatability experiment of two single qPCR.The left image shows the S2-HEX repeatability results:The template concentrations were 1&#8201;&#215;&#8201;10<sup>6</sup> copies /&#956;L, 1&#8201;&#215;&#8201;10<sup>5</sup> copies /&#956;L and 1&#8201;&#215;&#8201;10<sup>4</sup> copies /&#956;L; The right image shows the S2-HEX repeatability results:The template concentrations were 1&#8201;&#215;&#8201;10<sup>6</sup> copies /&#956;L, 1&#8201;&#215;&#8201;10<sup>5</sup> copies /&#956;L and 1&#8201;&#215;&#8201;10<sup>4</sup> copies /&#956;L</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO9" position="float" orientation="portrait" xlink:href="12917_2025_4635_Fig9_HTML.jpg"/></fig><table-wrap id="Tab5" position="float" orientation="portrait"><label>Table 5</label><caption><p>Repeatability experimental data of two single qPCR</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">probe</th><th align="left" rowspan="2" colspan="1">template concentration(copies/&#956;L)</th><th align="left" colspan="2" rowspan="1">Intragroup coefficient of variation</th><th align="left" colspan="2" rowspan="1">Intergroup coefficient of variation</th></tr><tr><th align="left" colspan="1" rowspan="1">Average number</th><th align="left" colspan="1" rowspan="1">Coefficient of variation (%)</th><th align="left" colspan="1" rowspan="1">Average number</th><th align="left" colspan="1" rowspan="1">Coefficient of variation (%)</th></tr></thead><tbody><tr><td align="left" rowspan="3" colspan="1">S2-HEX</td><td align="left" colspan="1" rowspan="1">1&#8201;&#215;&#8201;10<sup>4</sup></td><td align="left" colspan="1" rowspan="1">27.64</td><td align="left" colspan="1" rowspan="1">0.51</td><td align="left" colspan="1" rowspan="1">28.49</td><td align="left" colspan="1" rowspan="1">0.44</td></tr><tr><td align="left" colspan="1" rowspan="1">1&#8201;&#215;&#8201;10<sup>5</sup></td><td align="left" colspan="1" rowspan="1">24.35</td><td align="left" colspan="1" rowspan="1">0.54</td><td align="left" colspan="1" rowspan="1">25.18</td><td align="left" colspan="1" rowspan="1">0.57</td></tr><tr><td align="left" colspan="1" rowspan="1">1&#8201;&#215;&#8201;10<sup>6</sup></td><td align="left" colspan="1" rowspan="1">20.38</td><td align="left" colspan="1" rowspan="1">0.42</td><td align="left" colspan="1" rowspan="1">21.91</td><td align="left" colspan="1" rowspan="1">0.39</td></tr><tr><td align="left" rowspan="3" colspan="1">NS2-ROX</td><td align="left" colspan="1" rowspan="1">1&#8201;&#215;&#8201;10<sup>4</sup></td><td align="left" colspan="1" rowspan="1">28.45</td><td align="left" colspan="1" rowspan="1">0.45</td><td align="left" colspan="1" rowspan="1">27.82</td><td align="left" colspan="1" rowspan="1">0.46</td></tr><tr><td align="left" colspan="1" rowspan="1">1&#8201;&#215;&#8201;10<sup>5</sup></td><td align="left" colspan="1" rowspan="1">24.87</td><td align="left" colspan="1" rowspan="1">0.48</td><td align="left" colspan="1" rowspan="1">25.00</td><td align="left" colspan="1" rowspan="1">0.57</td></tr><tr><td align="left" colspan="1" rowspan="1">1&#8201;&#215;&#8201;10<sup>6</sup></td><td align="left" colspan="1" rowspan="1">21.61</td><td align="left" colspan="1" rowspan="1">0.43</td><td align="left" colspan="1" rowspan="1">20.79</td><td align="left" colspan="1" rowspan="1">0.43</td></tr></tbody></table></table-wrap></p></sec></sec><sec id="Sec33"><title>Duplex qPCR optimization results</title><sec id="Sec34"><title>Optimization results of duplex qPCR reaction system</title><p id="Par60">The chessboard method was used to optimize the amount of duplex qPCR primers and probes, and the amplification curve and Ct value were observed. The results showed that when the amount of primers was 0.8&#956;L, the Ct values of S2-HEX and NS2-ROX amplification curves were the smallest. When the amount of S2 probe and NS2 probe was 0.8&#956;L, the Ct values of S2-HEX and NS2-ROX amplification curves were the smallest. The optimization results of duplex qPCR reaction conditions are shown in Fig.&#160;<xref rid="Fig10" ref-type="fig">10</xref>, and the optimized reaction system is shown in Supplementary File 9.<fig id="Fig10" position="float" orientation="portrait"><label>Fig. 10</label><caption><p>Optimization of duplex qPCR reaction conditions.A,Primer concentration optimization: the amount of primers was 0.2&#956;L,0.4&#956;L,0.6&#956;L,0.8&#956;L and 1.0&#956;L, respectively;B,Probe concentration optimization: the amount of probe was 0.2&#956;L,0.4&#956;L,0.6&#956;L,0.8&#956;L and 1.0&#956;L, respectively. The S2-HEX group was the green curve and the NS2-ROX group was the orange curve</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO10" position="float" orientation="portrait" xlink:href="12917_2025_4635_Fig10_HTML.jpg"/></fig></p></sec><sec id="Sec35"><title>Results of duplex qPCR standard curve establishment</title><p id="Par61">With the optimized reaction conditions, the duplex qPCR standard curve was obtained by repeated experiments with two different concentrations of mixed plasmids as DNA templates (Fig.&#160;<xref rid="Fig11" ref-type="fig">11</xref>). The results of standard curve showed that the amplification efficiency of S2-HEX standard curve was 104.8%, and R<sup>2</sup> was 0.999. The amplification efficiency of NS2-ROX standard curve was 101.1%, and R<sup>2</sup> was 0.996. The results of duplex qPCR showed that the repeatability was high and the linear relationship was good, which could be used for the identification and analysis of subsequent samples.<fig id="Fig11" position="float" orientation="portrait"><label>Fig. 11</label><caption><p>Duplex qPCR standard curve.the amplification efficiency of S2-HEX standard curve was 104.8%, and R<sup>2</sup> was 0.999. The amplification efficiency of NS2-ROX standard curve was 101.1%, and R.<sup>2</sup> was 0.996</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO11" position="float" orientation="portrait" xlink:href="12917_2025_4635_Fig11_HTML.jpg"/></fig></p></sec><sec id="Sec36"><title>Experimental results of specificity and identification effect of duplex qPCR</title><p id="Par62">Two standard positive mixed plasmids were used as the positive control group, and RNase-free Water was used as the negative control group. The <italic toggle="yes">Brucella</italic> A19 vaccine strain DNA,<italic toggle="yes">Brucella</italic> S2 vaccine strain DNA,<italic toggle="yes">Brucella</italic> Rev1 vaccine strain DNA and genomic DNA extracted from <italic toggle="yes">Escherichia coli</italic>, <italic toggle="yes">Salmonella</italic>, <italic toggle="yes">Pediococcus acidilactici</italic> and <italic toggle="yes">Streptococcus</italic> were used as templates for duplex qPCR detection. The results showed that the <italic toggle="yes">Brucella</italic> S2 vaccine strain DNA had an amplification curve and Ct value at S2-HEX, but no amplification curve at NS2-ROX. The DNA of <italic toggle="yes">Brucella</italic> A19 and <italic toggle="yes">Brucella</italic> Rev.1 vaccine strains showed amplification curve and Ct value at NS2-ROX, but no amplification curve and Ct value at S2-HEX. The genomic DNA of <italic toggle="yes">Escherichia coli</italic>, <italic toggle="yes">Salmonella</italic>, <italic toggle="yes">Pediococcus acidilactici</italic> and <italic toggle="yes">Streptococcus</italic> did not show amplification curves, showing negative results (Fig.&#160;<xref rid="Fig12" ref-type="fig">12</xref>). The results showed that the method had good specificity and could identify <italic toggle="yes">Brucella</italic> S2 vaccine strain and natural virulent strain.<fig id="Fig12" position="float" orientation="portrait"><label>Fig. 12</label><caption><p>Duplex qPCR amplification curve of specificity and identification effect.The DNA of the <italic toggle="yes">Brucella</italic> S2 vaccine strain had an amplification curve at S2-HEX and no amplification curve at NS2-ROX. The DNA of <italic toggle="yes">the Brucella</italic> A19 and <italic toggle="yes">Brucella</italic> Rev.1 vaccine strains had amplification curves at NS2-ROX and no amplification curves at S2-HEX. There was no amplification curve in the genomic DNA of <italic toggle="yes">Escherichia coli, Salmonella, Pediococcus acidilactici and Streptococcus</italic></p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO12" position="float" orientation="portrait" xlink:href="12917_2025_4635_Fig12_HTML.jpg"/></fig></p></sec><sec id="Sec37"><title>Results of duplex qPCR sensitivity assay</title><p id="Par63">The optimized reaction conditions were used to detect mixed recombinant plasmids with template concentrations of 1&#8201;&#215;&#8201;10<sup>5</sup> copies / &#956;L, 1&#8201;&#215;&#8201;10<sup>4</sup> copies / &#956;L, 1&#8201;&#215;&#8201;10<sup>3</sup> copies / &#956;L, 1&#8201;&#215;&#8201;10<sup>2</sup> copies / &#956;L, and 1&#8201;&#215;&#8201;10<sup>1</sup> copies / &#956;L. The sensitivity of the duplex qPCR was evaluated, and the amplification curve was shown in Fig.&#160;<xref rid="Fig13" ref-type="fig">13</xref>. The experimental results showed that the minimum limit of detection for S2-HEX and NS2-ROX could reach 1&#8201;&#215;&#8201;10<sup>1</sup> copies / &#956;L, and the sensitivity was high, which proved that the established duplex qPCR differential diagnosis method could meet the requirements of clinical sample detection.<fig id="Fig13" position="float" orientation="portrait"><label>Fig. 13</label><caption><p>Duplex qPCR amplification curve of sensitivity experiment.Note: The two mixed plasmids were 1&#8201;&#215;&#8201;10<sup>5</sup>&#8211;1&#8201;&#215;&#8201;10<sup>1</sup> copies / &#956;L from left to right.The S2-HEX group was the green curve and the NS2-ROX group was the orange curve</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO13" position="float" orientation="portrait" xlink:href="12917_2025_4635_Fig13_HTML.jpg"/></fig></p><p id="Par64">The same mixed template concentration was used for conventional PCR amplification, and gel electrophoresis was used for sensitivity detection. The results showed that the minimum limit of detection was 1&#8201;&#215;&#8201;10<sup>3</sup> copies / &#956;L, and the sensitivity of qPCR method was about 100 times higher than that of conventional PCR, as shown in Fig. <xref rid="Fig14" ref-type="fig">14</xref>.<fig id="Fig14" position="float" orientation="portrait"><label>Fig. 14</label><caption><p>The results of PCR sensitivity test of mixed template. M:DL 2000 DNA Marker, lane 1:negative control, lanes 2:mixed DNA template positive control, 3
~ 8: mixed DNA template concentration 1 &#215; 10<sup>6</sup>copies / &#956;L, 1 &#215; 10<sup>5</sup>copies
/ &#956;L, 1 &#215; 10<sup>4</sup>copies / &#956;L, 1 &#215; 10<sup>3</sup>copies / &#956;L, 1 &#215; 10<sup>2</sup>copies
/ &#956;L, 1 &#215; 10<sup>1</sup>copies / &#956;L</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO14" position="float" orientation="portrait" xlink:href="12917_2025_4635_Fig14_HTML.jpg"/></fig></p></sec><sec id="Sec38"><title>Duplex qPCR repeatability test results</title><p id="Par65">The mixed recombinant plasmids with concentrations of 1&#8201;&#215;&#8201;10<sup>6</sup> copies / &#956;L, 1&#8201;&#215;&#8201;10<sup>5</sup> copies / &#956;L, and 1&#8201;&#215;&#8201;10<sup>4</sup> copies / &#956;L were used as templates to perform repetitive intragroup and intergroup experiments and replace different batches of reaction enzymes. The experimental results showed that the CV of Ct value within the group was less than 0.5%, and the CV of Ct value between groups was less than 0.7%, indicating that the duplex qPCR detection method established in this study had good repeatability. The results are shown in Table&#160;<xref rid="Tab6" ref-type="table">6</xref>.
<table-wrap id="Tab6" position="float" orientation="portrait"><label>Table 6</label><caption><p>Duplex qPCR repeated experimental results within and between groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">probe</th><th align="left" rowspan="2" colspan="1">template concentration (copies/&#956;L)</th><th align="left" colspan="2" rowspan="1">Intragroup coefficient of variation</th><th align="left" colspan="2" rowspan="1">Intergroup coefficient of variation</th></tr><tr><th align="left" colspan="1" rowspan="1">Mean ( Ct value)</th><th align="left" colspan="1" rowspan="1">Coefficient of variation ( %)</th><th align="left" colspan="1" rowspan="1">Mean ( Ct value)</th><th align="left" colspan="1" rowspan="1">Coefficient of variation ( %)</th></tr></thead><tbody><tr><td align="left" rowspan="3" colspan="1">S2-HEX</td><td align="left" colspan="1" rowspan="1">10<sup>4</sup></td><td align="left" colspan="1" rowspan="1">28.75</td><td align="left" colspan="1" rowspan="1">0.47</td><td align="left" colspan="1" rowspan="1">29.25</td><td align="left" colspan="1" rowspan="1">0.61</td></tr><tr><td align="left" colspan="1" rowspan="1">10<sup>5</sup></td><td align="left" colspan="1" rowspan="1">25.46</td><td align="left" colspan="1" rowspan="1">0.32</td><td align="left" colspan="1" rowspan="1">25.88</td><td align="left" colspan="1" rowspan="1">0.53</td></tr><tr><td align="left" colspan="1" rowspan="1">10<sup>6</sup></td><td align="left" colspan="1" rowspan="1">22.15</td><td align="left" colspan="1" rowspan="1">0.34</td><td align="left" colspan="1" rowspan="1">22.66</td><td align="left" colspan="1" rowspan="1">0.52</td></tr><tr><td align="left" rowspan="3" colspan="1">NS2-ROX</td><td align="left" colspan="1" rowspan="1">10<sup>4</sup></td><td align="left" colspan="1" rowspan="1">28.46</td><td align="left" colspan="1" rowspan="1">0.14</td><td align="left" colspan="1" rowspan="1">28.81</td><td align="left" colspan="1" rowspan="1">0.30</td></tr><tr><td align="left" colspan="1" rowspan="1">10<sup>5</sup></td><td align="left" colspan="1" rowspan="1">25.44</td><td align="left" colspan="1" rowspan="1">0.31</td><td align="left" colspan="1" rowspan="1">25.80</td><td align="left" colspan="1" rowspan="1">0.49</td></tr><tr><td align="left" colspan="1" rowspan="1">10<sup>6</sup></td><td align="left" colspan="1" rowspan="1">22.12</td><td align="left" colspan="1" rowspan="1">0.39</td><td align="left" colspan="1" rowspan="1">22.67</td><td align="left" colspan="1" rowspan="1">0.44</td></tr></tbody></table></table-wrap></p></sec></sec><sec id="Sec39"><title>Application results of duplex qPCR method for differential detection of Brucella S2 vaccine strain</title><sec id="Sec40"><title>The results of Brucella in whole blood bacteria resident rule</title><p id="Par66">The results of Rose-Bengal plate-agglutination test, tube agglutination test and iELISA of 30 selected goat were all negative.</p><p id="Par67">Based on the established duplex qPCR differential diagnosis method for the <italic toggle="yes">Brucella</italic> S2 vaccine strain, the bacterial residence rule of the recommended dose group after immunization with the <italic toggle="yes">Brucella</italic> S2 vaccine was shown in Figs. <xref rid="Fig15" ref-type="fig">15</xref>&#160;and <xref rid="Fig17" ref-type="fig">17</xref>. The Ct values of bacterial residence are shown in Tables <xref rid="Tab7" ref-type="table">7</xref> and <xref rid="Tab8" ref-type="table">8</xref>. The rule of bacterial residence in the double dose group: as shown in Figs. <xref rid="Fig16" ref-type="fig">16</xref> and <xref rid="Fig17" ref-type="fig">17</xref> and the Ct value of bacterial residence is shown in Tables <xref rid="Tab9" ref-type="table">9</xref>&#160;and&#160;<xref rid="Tab10" ref-type="table">10</xref>.<fig id="Fig15" position="float" orientation="portrait"><label>Fig. 15</label><caption><p><bold>A&#160;</bold>0~60 d recommend dose amplification&#160;curve1, <bold>B</bold> 0~60 d recommend dose amplification curve2, <bold>C</bold> 90 d and 120 d recommend dose amplification curve.1:Positive control,2:Partial samples,3:Partial samples andnegative controls</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO15" position="float" orientation="portrait" xlink:href="12917_2025_4635_Fig15_HTML.jpg"/></fig><table-wrap id="Tab7" position="float" orientation="portrait"><label>Table 7</label><caption><p>Recommend dose bacterial residual Ct value1</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="3" colspan="1">Days</th><th align="left" colspan="10" rowspan="1">Recommend dose</th></tr><tr><th align="left" colspan="2" rowspan="1">1</th><th align="left" colspan="2" rowspan="1">2</th><th align="left" colspan="2" rowspan="1">3</th><th align="left" colspan="2" rowspan="1">4</th><th align="left" colspan="2" rowspan="1">5</th></tr><tr><th align="left" colspan="1" rowspan="1">HEX</th><th align="left" colspan="1" rowspan="1">ROX</th><th align="left" colspan="1" rowspan="1">HEX</th><th align="left" colspan="1" rowspan="1">ROX</th><th align="left" colspan="1" rowspan="1">HEX</th><th align="left" colspan="1" rowspan="1">ROX</th><th align="left" colspan="1" rowspan="1">HEX</th><th align="left" colspan="1" rowspan="1">ROX</th><th align="left" colspan="1" rowspan="1">HEX</th><th align="left" colspan="1" rowspan="1">ROX</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Immunization 0 d</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">38</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">38.07</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">36.38</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 3 d</td><td align="left" colspan="1" rowspan="1">32.65</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">34.42</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">35.14</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">32.95</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">34.27</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 5 d</td><td align="left" colspan="1" rowspan="1">33.76</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">32.62</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">33.02</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">32.08</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">31.87</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 7 d</td><td align="left" colspan="1" rowspan="1">33.29</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">32.44</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">34.52</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">32.75</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">34.27</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 15 d</td><td align="left" colspan="1" rowspan="1">32.65</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">31.28</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">31.64</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">32.75</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">28.55</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 21 d</td><td align="left" colspan="1" rowspan="1">34.09</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">33.66</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">33.98</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">33.03</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">32.93</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 30 d</td><td align="left" colspan="1" rowspan="1">33.53</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">34.41</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">31.95</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">32.97</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">34.10</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 60 d</td><td align="left" colspan="1" rowspan="1">33.14</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">34.48</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">35.04</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">34.8</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">34.38</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 90 d</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">36.14</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">35.34</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">36.16</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">36.53</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 120 d</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">35.31</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">37.21</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">36.26</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 150 d</td><td align="left" colspan="1" rowspan="1">37.77</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">38.57</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">38.57</td><td align="left" colspan="1" rowspan="1">39.91</td><td align="left" colspan="1" rowspan="1">37.82</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 180 d</td><td align="left" colspan="1" rowspan="1">37.98</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">38.01</td><td align="left" colspan="1" rowspan="1">37.30</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">38.12</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">36.52</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 210 d</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">37.88</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 240 d</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr></tbody></table></table-wrap><table-wrap id="Tab8" position="float" orientation="portrait"><label>Table 8</label><caption><p>Recommend dose bacterial residual Ct value 2</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="3" colspan="1">Days</th><th align="left" colspan="10" rowspan="1">Recommend dose</th></tr><tr><th align="left" colspan="2" rowspan="1">6</th><th align="left" colspan="2" rowspan="1">7</th><th align="left" colspan="2" rowspan="1">8</th><th align="left" colspan="2" rowspan="1">9</th><th align="left" colspan="2" rowspan="1">10</th></tr><tr><th align="left" colspan="1" rowspan="1">HEX</th><th align="left" colspan="1" rowspan="1">ROX</th><th align="left" colspan="1" rowspan="1">HEX</th><th align="left" colspan="1" rowspan="1">ROX</th><th align="left" colspan="1" rowspan="1">HEX</th><th align="left" colspan="1" rowspan="1">ROX</th><th align="left" colspan="1" rowspan="1">HEX</th><th align="left" colspan="1" rowspan="1">ROX</th><th align="left" colspan="1" rowspan="1">HEX</th><th align="left" colspan="1" rowspan="1">ROX</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Immunization 0 d</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">38.59</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">36.78</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 3 d</td><td align="left" colspan="1" rowspan="1">34.92</td><td align="left" colspan="1" rowspan="1">35.44</td><td align="left" colspan="1" rowspan="1">34.61</td><td align="left" colspan="1" rowspan="1">38.98</td><td align="left" colspan="1" rowspan="1">33.42</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">36.45</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">33.30</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 5 d</td><td align="left" colspan="1" rowspan="1">34.67</td><td align="left" colspan="1" rowspan="1">35.04</td><td align="left" colspan="1" rowspan="1">36.56</td><td align="left" colspan="1" rowspan="1">39.91</td><td align="left" colspan="1" rowspan="1">34.54</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">36.10</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 7 d</td><td align="left" colspan="1" rowspan="1">35.25</td><td align="left" colspan="1" rowspan="1">36.10</td><td align="left" colspan="1" rowspan="1">35.72</td><td align="left" colspan="1" rowspan="1">39.19</td><td align="left" colspan="1" rowspan="1">34.96</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">32.41</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">34.40</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 15 d</td><td align="left" colspan="1" rowspan="1">31.72</td><td align="left" colspan="1" rowspan="1">37.39</td><td align="left" colspan="1" rowspan="1">33.35</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">30.02</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">31.06</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">33.54</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 21 d</td><td align="left" colspan="1" rowspan="1">33.53</td><td align="left" colspan="1" rowspan="1">36.97</td><td align="left" colspan="1" rowspan="1">32.51</td><td align="left" colspan="1" rowspan="1">38.13</td><td align="left" colspan="1" rowspan="1">34.20</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">34.58</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">36.57</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 30 d</td><td align="left" colspan="1" rowspan="1">34.96</td><td align="left" colspan="1" rowspan="1">37.28</td><td align="left" colspan="1" rowspan="1">34.54</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">36.13</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">37.33</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 60 d</td><td align="left" colspan="1" rowspan="1">37.54</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">34.43</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">38.12</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">35.77</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">35.76</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 90 d</td><td align="left" colspan="1" rowspan="1">35.89</td><td align="left" colspan="1" rowspan="1">38.59</td><td align="left" colspan="1" rowspan="1">36.16</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">35.36</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">36.23</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">32.85</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 120 d</td><td align="left" colspan="1" rowspan="1">37.09</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">34.26</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">38.2</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 150 d</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">35.43</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">36.32</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">36.47</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">38.85</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 180 d</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">34.53</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">38.46</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">38.57</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 210 d</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">35.02</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 240 d</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">36.98</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr></tbody></table></table-wrap><fig id="Fig16" position="float" orientation="portrait"><label>Fig. 16</label><caption><p><bold>A </bold>0~60 d double dose amplification curve1,&#160;<bold>B </bold>0~60 d double dose amplification curve2,&#160;<bold>C</bold> 90 d and 120 d double dose amplification curve.1:Positive control,2:Partial samples,3:Partial samples and negative controls</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO16" position="float" orientation="portrait" xlink:href="12917_2025_4635_Fig16_HTML.jpg"/></fig><fig id="Fig17" position="float" orientation="portrait"><label>Fig. 17</label><caption><p>
<bold>A </bold>150 d recommend and doubled dose amplification curve,<bold> B </bold>180 d recommend and doubled dose amplification curve,&#160;<bold>C </bold>210 d recommend and double dose amplification curve,<bold> D </bold>240 d recommend and double dose amplification curve<bold>.</bold>1:Positive control,2:Partial samples,3:Partial samples and negative controls.&#160;Note : The S2 vaccine strain ( HEX ) is a green curve, and the wild strain ( ROX ) is an orange curve
</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO17" position="float" orientation="portrait" xlink:href="12917_2025_4635_Fig17_HTML.jpg"/></fig><table-wrap id="Tab9" position="float" orientation="portrait"><label>Table 9</label><caption><p>Double dose bacterial residual Ct value 1</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="3" colspan="1">Days</th><th align="left" colspan="10" rowspan="1">Double dose</th></tr><tr><th align="left" colspan="2" rowspan="1">16</th><th align="left" colspan="2" rowspan="1">17</th><th align="left" colspan="2" rowspan="1">18</th><th align="left" colspan="2" rowspan="1">19</th><th align="left" colspan="2" rowspan="1">20</th></tr><tr><th align="left" colspan="1" rowspan="1">HEX</th><th align="left" colspan="1" rowspan="1">ROX</th><th align="left" colspan="1" rowspan="1">HEX</th><th align="left" colspan="1" rowspan="1">ROX</th><th align="left" colspan="1" rowspan="1">HEX</th><th align="left" colspan="1" rowspan="1">ROX</th><th align="left" colspan="1" rowspan="1">HEX</th><th align="left" colspan="1" rowspan="1">ROX</th><th align="left" colspan="1" rowspan="1">HEX</th><th align="left" colspan="1" rowspan="1">ROX</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Immunization 0 d</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">38.97</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">37.92</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 3 d</td><td align="left" colspan="1" rowspan="1">34.42</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">34.43</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">33.97</td><td align="left" colspan="1" rowspan="1">37.21</td><td align="left" colspan="1" rowspan="1">33.18</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">34.74</td><td align="left" colspan="1" rowspan="1">38.80</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 5 d</td><td align="left" colspan="1" rowspan="1">33.81</td><td align="left" colspan="1" rowspan="1">38.63</td><td align="left" colspan="1" rowspan="1">34.09</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">33.68</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">33.27</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">35.21</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 7 d</td><td align="left" colspan="1" rowspan="1">33.12</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">34.35</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">33.48</td><td align="left" colspan="1" rowspan="1">37.76</td><td align="left" colspan="1" rowspan="1">33.13</td><td align="left" colspan="1" rowspan="1">37.52</td><td align="left" colspan="1" rowspan="1">33.98</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 15 d</td><td align="left" colspan="1" rowspan="1">32.47</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">31.77</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">30.16</td><td align="left" colspan="1" rowspan="1">38.28</td><td align="left" colspan="1" rowspan="1">31.98</td><td align="left" colspan="1" rowspan="1">39.89</td><td align="left" colspan="1" rowspan="1">32.20</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 21 d</td><td align="left" colspan="1" rowspan="1">34.45</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">32.28</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">32.33</td><td align="left" colspan="1" rowspan="1">38.59</td><td align="left" colspan="1" rowspan="1">33.89</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">34.28</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 30 d</td><td align="left" colspan="1" rowspan="1">34.75</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">35.75</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">34.25</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">34.41</td><td align="left" colspan="1" rowspan="1">39.30</td><td align="left" colspan="1" rowspan="1">35.57</td><td align="left" colspan="1" rowspan="1">37.26</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 60 d</td><td align="left" colspan="1" rowspan="1">36.55</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">36.10</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">34.61</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">36.18</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">35.27</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 90 d</td><td align="left" colspan="1" rowspan="1">36.25</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">35.15</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">36.38</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">35.98</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">35.48</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 120 d</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">36.21</td><td align="left" colspan="1" rowspan="1">37.46</td><td align="left" colspan="1" rowspan="1">37.15</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">36.64</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 150 d</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">39.91</td><td align="left" colspan="1" rowspan="1">37.39</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">36.32</td><td align="left" colspan="1" rowspan="1">39.76</td><td align="left" colspan="1" rowspan="1">38.94</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 180 d</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">38.09</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">37.91</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">34.72</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">37.11</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 210 d</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 240 d</td><td align="left" colspan="1" rowspan="1">38.71</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">38.03</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">38.55</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr></tbody></table></table-wrap><table-wrap id="Tab10" position="float" orientation="portrait"><label>Table 10</label><caption><p>Double dose bacterial residual Ct value 2</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="3" colspan="1">Days</th><th align="left" colspan="10" rowspan="1">Double dose</th></tr><tr><th align="left" colspan="2" rowspan="1">21</th><th align="left" colspan="2" rowspan="1">22</th><th align="left" colspan="2" rowspan="1">23</th><th align="left" colspan="2" rowspan="1">24</th><th align="left" colspan="2" rowspan="1">25</th></tr><tr><th align="left" colspan="1" rowspan="1">HEX</th><th align="left" colspan="1" rowspan="1">ROX</th><th align="left" colspan="1" rowspan="1">HEX</th><th align="left" colspan="1" rowspan="1">ROX</th><th align="left" colspan="1" rowspan="1">HEX</th><th align="left" colspan="1" rowspan="1">ROX</th><th align="left" colspan="1" rowspan="1">HEX</th><th align="left" colspan="1" rowspan="1">ROX</th><th align="left" colspan="1" rowspan="1">HEX</th><th align="left" colspan="1" rowspan="1">ROX</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Immunization 0 d</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">37.98</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">38.75</td><td align="left" colspan="1" rowspan="1">37.26</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">37.51</td><td align="left" colspan="1" rowspan="1">38.13</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 3 d</td><td align="left" colspan="1" rowspan="1">34.53</td><td align="left" colspan="1" rowspan="1">38.81</td><td align="left" colspan="1" rowspan="1">33.18</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">36.16</td><td align="left" colspan="1" rowspan="1">37.47</td><td align="left" colspan="1" rowspan="1">34.22</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">38.44</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 5 d</td><td align="left" colspan="1" rowspan="1">33.36</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">31.27</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">34.90</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">34.11</td><td align="left" colspan="1" rowspan="1">38.81</td><td align="left" colspan="1" rowspan="1">39.98</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 7 d</td><td align="left" colspan="1" rowspan="1">32.93</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">33.01</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">34.28</td><td align="left" colspan="1" rowspan="1">37.98</td><td align="left" colspan="1" rowspan="1">34.49</td><td align="left" colspan="1" rowspan="1">37.91</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 15 d</td><td align="left" colspan="1" rowspan="1">33.03</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">31.79</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">31.61</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">33.42</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 21 d</td><td align="left" colspan="1" rowspan="1">34.59</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">30.59</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">32.25</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">34.38</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 30 d</td><td align="left" colspan="1" rowspan="1">33.65</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">32.25</td><td align="left" colspan="1" rowspan="1">37.30</td><td align="left" colspan="1" rowspan="1">33.30</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">35.01</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 60 d</td><td align="left" colspan="1" rowspan="1">34.14</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">32.15</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">33.45</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">35.85</td><td align="left" colspan="1" rowspan="1">38.01</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 90 d</td><td align="left" colspan="1" rowspan="1">38.19</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">37.51</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">37.54</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">36.04</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 120 d</td><td align="left" colspan="1" rowspan="1">37.29</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">36.72</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">36.32</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 150 d</td><td align="left" colspan="1" rowspan="1">36.87</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">36.19</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">36.74</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">39.76</td><td align="left" colspan="1" rowspan="1">38.42</td><td align="left" colspan="1" rowspan="1">39.64</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 180 d</td><td align="left" colspan="1" rowspan="1">36.73</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">37.40</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">37.71</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 210 d</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">39.01</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunization 240 d</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">38.28</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr></tbody></table></table-wrap></p><p id="Par68">By Tables 7 and 8, it can be seen that <italic toggle="yes">Brucella</italic> nucleic acid can be detected by this method after 3&#160;days of oral recommended dose <italic toggle="yes">Brucella</italic> S2 vaccine immunization, and the Ct value is the lowest after 15&#160;days of immunization. <italic toggle="yes">Brucella</italic> nucleic acid can still be detected at 180&#160;days and 210&#160;days after immunization, and <italic toggle="yes">Brucella</italic> nucleic acid is not detected at 240&#160;days after immunization. Tables <xref rid="Tab9" ref-type="table">9</xref> and <xref rid="Tab10" ref-type="table">10</xref> show that <italic toggle="yes">Brucella</italic> nucleic acid can also be detected by this method after 3&#160;days of oral double dose <italic toggle="yes">Brucella</italic> S2 vaccine immunization, and the Ct value is the lowest after 15&#160;days of immunization. <italic toggle="yes">Brucella</italic> nucleic acid can still be detected at 180&#160;days after immunization, and <italic toggle="yes">Brucella</italic> nucleic acid is not detected at 210&#160;days and 240&#160;days after immunization.
</p></sec><sec id="Sec41"><title>Detection results of <italic toggle="yes">Brucella</italic> vaccine bacteria residence in goat milk</title><p id="Par69">Using the established duplex qPCR differential diagnosis method of <italic toggle="yes">Brucella</italic> S2 vaccine strain, 5 samples were detected to be positive for <italic toggle="yes">Brucella</italic> S2 vaccine strain in 10 samples of <italic toggle="yes">Brucella</italic> antibody-positive goat milk, and 2 samples were detected to be positive for <italic toggle="yes">Brucella</italic> S2 vaccine strain mixed with wild strain. The amplification curve results are shown in Fig.&#160;<xref rid="Fig18" ref-type="fig">18</xref>(A), and the Ct value is shown in Table&#160;<xref rid="Tab11" ref-type="table">11</xref>. Among the selected 10 negative goat milk controls, 2 samples were detected to be positive for the <italic toggle="yes">Brucella</italic> S2 vaccine strain, and 1 sample was detected to be positive for the <italic toggle="yes">Brucella</italic> S2 vaccine strain mixed with the wild strain. The results of the amplification curve are shown in Fig. <xref rid="Fig18" ref-type="fig">18</xref>(B), and the results of the Ct value are shown in Table <xref rid="Tab12" ref-type="table">12</xref>.
<fig id="Fig18" position="float" orientation="portrait"><label>Fig. 18</label><caption><p><bold>A </bold>Residual amplification curves of bacteria in positive goat milk,&#160;<bold>B</bold> Residual amplification curves of bacteria in negative goat milk.1:Positive control,2:Partial samples,3:Partial samples and negative controls</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO18" position="float" orientation="portrait" xlink:href="12917_2025_4635_Fig18_HTML.jpg"/></fig><table-wrap id="Tab11" position="float" orientation="portrait"><label>Table 11</label><caption><p>Bacteria-resident Ct values in positive goat's milk</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Number</th><th align="left" colspan="1" rowspan="1">HEX</th><th align="left" colspan="1" rowspan="1">ROX</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">34.11</td><td align="left" colspan="1" rowspan="1">32.78</td></tr><tr><td align="left" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">32.99</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">3</td><td align="left" colspan="1" rowspan="1">32.45</td><td align="left" colspan="1" rowspan="1">36.38</td></tr><tr><td align="left" colspan="1" rowspan="1">4</td><td align="left" colspan="1" rowspan="1">33.08</td><td align="left" colspan="1" rowspan="1">32.36</td></tr><tr><td align="left" colspan="1" rowspan="1">5</td><td align="left" colspan="1" rowspan="1">32.57</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">6</td><td align="left" colspan="1" rowspan="1">38.51</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">7</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">8</td><td align="left" colspan="1" rowspan="1">34.38</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">9</td><td align="left" colspan="1" rowspan="1">31.40</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">10</td><td align="left" colspan="1" rowspan="1">37.46</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr></tbody></table></table-wrap><table-wrap id="Tab12" position="float" orientation="portrait"><label>Table 12</label><caption><p>Bacteria-resident Ct values in negative goat's milk</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Number</th><th align="left" colspan="1" rowspan="1">HEX</th><th align="left" colspan="1" rowspan="1">ROX</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Y1</td><td align="left" colspan="1" rowspan="1">34.64</td><td align="left" colspan="1" rowspan="1">30.81</td></tr><tr><td align="left" colspan="1" rowspan="1">Y2</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Y3</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Y4</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Y5</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Y6</td><td align="left" colspan="1" rowspan="1">33.59</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Y7</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Y8</td><td align="left" colspan="1" rowspan="1">32.72</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Y9</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr><tr><td align="left" colspan="1" rowspan="1">Y10</td><td align="left" colspan="1" rowspan="1">&#8212;</td><td align="left" colspan="1" rowspan="1">&#8212;</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec42"><title>Clinical sample detection</title><p id="Par70">A total of 64 sheep blood samples were detected by the established duplex qPCR differential diagnosis method for the <italic toggle="yes">Brucella</italic> S2 vaccine strain. A total of 64 <italic toggle="yes">Brucella</italic> positive samples were detected, including 44 <italic toggle="yes">Brucella</italic> S2 vaccine positive samples and 20 mixed infection samples. The results are shown in Fig.&#160;<xref rid="Fig19" ref-type="fig">19</xref>.
<fig id="Fig19" position="float" orientation="portrait"><label>Fig. 19</label><caption><p>The qPCR amplification curve of clinical samples.1:Positive control,2:Partial samples,3:Partial samples and negative controls</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO19" position="float" orientation="portrait" xlink:href="12917_2025_4635_Fig19_HTML.jpg"/></fig></p></sec></sec></sec><sec id="Sec43"><title>Discussion</title><p id="Par71">Brucellosis is an important zoonotic infectious disease that endangers public health security and the healthy development of animal husbandry [<xref ref-type="bibr" rid="CR24">24</xref>]. It is widely popular around the world, especially in countries and regions with more developed agriculture and animal husbandry.Because the symptoms of brucellosis are complex and diverse, and similar to many other diseases, the diagnosis requires laboratory testing [<xref ref-type="bibr" rid="CR25">25</xref>]. At present, the laboratory diagnosis methods of brucellosis mainly include etiological detection and serological detection. Bacterial culture is considered to be the gold standard for diagnosis. Molecular biology method, nucleic acid amplification detection, can detect <italic toggle="yes">Brucella</italic> within a few hours, with high sensitivity and specificity. The methods of nucleic acid amplification detection include conventional PCR technology, nested PCR, real-time PCR, multiple real-time PCR and so on [<xref ref-type="bibr" rid="CR26">26</xref>]. At present, the vaccines that can be used to prevent sheep brucellosis in China include <italic toggle="yes">Brucella melitensis</italic> Rev.1 strain, <italic toggle="yes">Brucella melitensis</italic> M5 / M5-90 strain, <italic toggle="yes">Brucella suis</italic> S2 strain and other conventional attenuated vaccines. The shortcomings of these vaccines are as follows: First, the safety is not enough, and the injection of pregnant animals will cause abortion; second, the vaccine strain and the wild strain are both smooth, which interferes with clinical diagnosis after immunization [<xref ref-type="bibr" rid="CR27">27</xref>]. Therefore, the prevention and control of the disease is of great significance for ensuring the safety of meat and dairy products [<xref ref-type="bibr" rid="CR28">28</xref>].</p><p id="Par72">TaqMan qPCR is a nucleic acid quantitative technology based on PCR qualitative technology. It is a method that has been widely used in nucleic acid detection and quantification. The TaqMan qPCR method is based on the use of specific primers and probes to bind to the target DNA sequence and generate a fluorescent signal during the amplification process. Compared with the qPCR directly added with fluorescent dyes, the specificity is stronger.Compared with conventional TaqMan probes, MGB probes have two major characteristics: one is that the 3' end of the probe is labeled with a quencher molecule that does not emit itself to replace conventional fluorescent markers such as TAMRA that can emit light. This reduces the fluorescence background and greatly improves the fluorescence spectral resolution. Second, MGB was added to the 3' end of the probe. MGB can stabilize the hybridization between the probe and the template and increase the annealing temperature of the probe. On the one hand, the length of the probe is shortened, the distance between the fluorescent group and the quenching group is closer, and the quenching effect is better. On the other hand, it also improves the specificity of the probe, making the results more accurate and higher resolution.Chang et al.established the TaqMan qPCR detection method based on <italic toggle="yes">Brucella IS711 gene</italic> sequence, with a limit of detection 3.8 copy/&#956;L, which is characterized by high sensitivity, strong specificity, and simple operation, and can be used as a reliable clinical detection method for <italic toggle="yes">Brucella</italic> [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. Liu et al.designed primers and probes with <italic toggle="yes">Brucella Bcsp31</italic> gene as the target gene to evaluate the sensitivity, repeatability and specificity of the droplet digital PCR ( ddPCR) method for detecting <italic toggle="yes">Brucella</italic>. The results showed that the established ddPCR method for detecting <italic toggle="yes">Brucella</italic> had high sensitivity, the minimum limit of detection was 100 copies / &#956;L, and the detection of <italic toggle="yes">Brucella</italic> showed good specificity and accuracy [<xref ref-type="bibr" rid="CR30">30</xref>]. Suman et al.developed qPCR primers targeting the <italic toggle="yes">Omp31 gene</italic> and designed primers using the discontinuous conserved sequence of the <italic toggle="yes">Omp31 gene</italic>. The <italic toggle="yes">Omp31</italic> probe was designed by connecting a 6-FAM reporter dye at the 5 ' end and a BHQ-1 quencher at the 3 ' end. The TaqMan &#174; probe real-time detection method of <italic toggle="yes">Omp31 gene</italic> has the advantages of simplicity, rapidity, sensitivity and specificity. As low as 100&#160;fg of <italic toggle="yes">Brucella</italic> nucleic acid can be detected [<xref ref-type="bibr" rid="CR31">31</xref>]. Nan Wenlong et al.designed <italic toggle="yes">IclR</italic> primers based on the deletion of 25 bases ( bp) in the genome of <italic toggle="yes">Brucella suis</italic> S2. In the published papers ( Bricker et al., 1994), <italic toggle="yes">IS711</italic> primers were screened, <italic toggle="yes">IS711</italic> primers were used to identify wild strains of <italic toggle="yes">Brucella suis</italic> type 1, <italic toggle="yes">IclR</italic> primers and <italic toggle="yes">IS711</italic> primers were used to identify <italic toggle="yes">Brucella suis</italic> S2 vaccine strains. It was verified that DNA can be detected at a concentration of as low as 60&#160;fg. The duplex PCR method is sensitive and specific. It can distinguish <italic toggle="yes">Brucella suis</italic> biotype <italic toggle="yes">S2 and Brucella suis</italic> biotype 1 from other common species and biotypes of <italic toggle="yes">Brucella</italic>, four <italic toggle="yes">Brucella</italic> vaccine strains ( 104&#160;M, BA19, S19 and M5) and four non-<italic toggle="yes">Brucella</italic> ( <italic toggle="yes">Escherichia coli K99</italic>, <italic toggle="yes">Pasteurella multocida C48-1</italic>, <italic toggle="yes">Streptococcus suis ST171</italic>, <italic toggle="yes">Pseudomonas aeruginosa DI-1</italic>) [<xref ref-type="bibr" rid="CR32">32</xref>].</p><p id="Par73">In this study, the whole genome sequence of <italic toggle="yes">Brucella</italic> S2 vaccine strain and the whole genome sequence of natural virulent strain 1330 were compared by SnapGene software. Firstly, the differential sequences between the two <italic toggle="yes">Brucella</italic> strains were found. A total of 25 differential gene fragments were screened out. The 25 differential gene fragments were subjected to BLAST specificity verification on NCBI, and 23 of them had low coverage and no specificity. Only the 25&#160;bp deletion at 246,928 on chromosome I of the <italic toggle="yes">Brucella</italic> S2 vaccine strain and the 1&#160;bp deletion at 1,064,715 on chromosome II of the <italic toggle="yes">Brucella</italic> S2 vaccine strain have a high coverage, and can distinguish the <italic toggle="yes">Brucella</italic> S2 vaccine strain from other <italic toggle="yes">Brucella</italic> strains, of which the 25&#160;bp deletion fragment has been reported.Therefore, in this experiment, the 1&#160;bp deletion on chromosome II of <italic toggle="yes">Brucella</italic> S2 vaccine strain was selected as the nucleic acid marker sequence. After PCR amplification and sequencing analysis, it was determined that it could be used as the marker sequence of <italic toggle="yes">Brucella</italic> S2 vaccine strain for subsequent differential diagnosis. This paper can provide a method for the differential diagnosis of <italic toggle="yes">Brucella</italic> S2 vaccine strain. By designing primers and probes for the specific sequence of the <italic toggle="yes">Brucella</italic> S2 vaccine strain, two S2-HEX probes were designed. After the detection of S2-HEX-2 probe by qPCR, the <italic toggle="yes">Brucella</italic> S2 vaccine strain could not be distinguished from other strains, and it was not specific. Therefore, S2-HEX-1 probe was selected for subsequent experiments.Firstly, a single qPCR detection method for <italic toggle="yes">Brucella</italic> was established. After verifying its feasibility through experiments, two single qPCR detection methods for <italic toggle="yes">Brucella</italic> were combined to verify the compatibility and matching effect between primers and probes. Finally, a duplex qPCR differential diagnosis method for specific deletion sites of <italic toggle="yes">Brucella</italic> S2 vaccine strain was optimized and established.</p><p id="Par74">The established duplex qPCR detection method of <italic toggle="yes">Brucella</italic> S2 vaccine strain can effectively identify whether the positive samples detected by Rose-Bengal plate-agglutination test and tube agglutination test belong to S2 vaccine immune antibody or other vaccine antibody and wild virus infection antibody, which provides a certain reference for quarantine and purification of positive livestock.By immunizing goat with normal dose and double dose of <italic toggle="yes">Brucella</italic> S2 vaccine, it can be shown that <italic toggle="yes">Brucella</italic> nucleic acid can be detected in the blood three days after immunization, and the Ct value is the smallest on the 15 th day, indicating that the bacterial content in the body is the largest, and then the amount of bacteria begins to decrease, and the retention of <italic toggle="yes">Brucella</italic> nucleic acid in the animal body is not detected on the 240 th day after immunization.The presence of the <italic toggle="yes">Brucella</italic> S2 vaccine strain and other vaccine and wild strains in goat milk was detected, indicating that <italic toggle="yes">Brucella</italic> can exist in the mammary gland tissue of infected dairy goats and then enter the goat milk. In the negative samples, some goat were detected by <italic toggle="yes">Brucella</italic> S2 vaccine duplex qPCR differential diagnosis method to detect <italic toggle="yes">Brucella</italic> S2 vaccine nucleic acid or other vaccine and wild virus nucleic acid. It is speculated that the experimental goat may be orally administered <italic toggle="yes">Brucella</italic> S2 vaccine, resulting in aerosol pollution in the air, so that the non-immunized goat showed <italic toggle="yes">Brucella</italic> S2 vaccine positive, while the wild strain infection may be caused by vertical transmission of the goat by the female livestock through the birth canal infection or horizontal transmission. Because the <italic toggle="yes">Brucella</italic> antibody positive herd was not raised in time, the negative goat was infected. This indicates that immunized animals and non-immunized animals should be kept in isolation, and the enclosure of immunized animals should pay attention to the environment, disinfection of utensils, etc. To prevent aerosol pollution.From the establishment of <italic toggle="yes">Brucella</italic> S2 vaccine strain differential diagnosis method to clinical sample detection, the establishment of the method to the application of the method was realized. It can solve the technical problems of the lack of differential diagnosis methods of brucellosis in production practice, provide technical support for the effective control of the disease, and is of great significance for the purification and prevention and control of the disease.</p></sec><sec id="Sec44"><title>Conclusions</title><p id="Par75">In this study, TaqMan probe-based qPCR technology was used to study the molecular biological identification method of <italic toggle="yes">Brucella</italic> by combining the differential genes between the <italic toggle="yes">Brucella</italic> S2 vaccine strain and the natural virulent strain.Compared with serological detection and conventional PCR detection,this method has the characteristics of less DNA consumption, 100 times higher sensitivity, short detection time, and about one and a half hours from the configuration of the system to the end of the program operation. And Only one pair of primers and two probes can be detected. The minimum limit of detection can reach 10 copies/&#956;L.and it can effectively identify <italic toggle="yes">Brucella</italic> S2 vaccine strain and other <italic toggle="yes">Brucella</italic> strains.It provides a new method for the differential diagnosis of the <italic toggle="yes">Brucella</italic> S2 vaccine strain, which can contribute to the prevention and control of <italic toggle="yes">Brucella</italic>.After immunizing dairy goats with the <italic toggle="yes">Brucella</italic> S2 vaccine,the results showed that the nucleic acid of vaccine bacteria could be detected in the recommended dose group for 3&#160;days, and the bacterial content was the largest at 15&#160;days. The bacterial content began to decrease at 30&#160;days, and all nucleic acid tests were negative at 240&#160;days. The nucleic acid of vaccine bacteria could be detected in the double dose group at 3 d, the bacterial content was the highest at 15 d, the bacterial content began to decrease at 21 d, and the nucleic acid detection was negative at 210 d and 240 d. <italic toggle="yes">Brucella</italic> can also be detected in goat milk by this method, and <italic toggle="yes">Brucella</italic> can be detected in clinical samples.</p></sec><sec id="Sec45" sec-type="supplementary-material"><title>Supplementary Information</title><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="12917_2025_4635_MOESM1_ESM.docx" position="float" orientation="portrait"><caption><p>Supplementary Material 1.</p></caption></media></supplementary-material></p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>PCR</term><def><p id="Par4">Polymerase chain reaction</p></def></def-item><def-item><term>qPCR</term><def><p id="Par5">Quantitative Polymerase Chain Reaction</p></def></def-item><def-item><term>RBPT</term><def><p id="Par6">Rose-Bengal plate-agglutination test</p></def></def-item><def-item><term>ELISA</term><def><p id="Par7">Enzyme linked immunosorbent assay</p></def></def-item><def-item><term>cELISA</term><def><p id="Par8">Competitive enzyme linked immunosorbent assay</p></def></def-item><def-item><term>iELISA</term><def><p id="Par9">Indirect enzyme linked immunosorbent assay</p></def></def-item><def-item><term>GICA</term><def><p id="Par10">Gold lmmuno-chromatographic Assay</p></def></def-item><def-item><term>LAMP</term><def><p id="Par11">Loop-Mediated Isothermal Amplification</p></def></def-item><def-item><term>MRT</term><def><p id="Par12">Whole milk ring agglutination test</p></def></def-item><def-item><term>FPA</term><def><p id="Par13">Fluorescence polarization assay</p></def></def-item><def-item><term>SAT</term><def><p id="Par14">Tube agglutination test</p></def></def-item><def-item><term>RPA</term><def><p id="Par15">Recombinase polymerase amplification</p></def></def-item><def-item><term>CFT</term><def><p id="Par16">Complement fixation test</p></def></def-item><def-item><term>PCR-RFLP</term><def><p id="Par17">Polymerase Chain Reaction-Restriction Fragment Length Polymorphism</p></def></def-item><def-item><term>ERIC-PCR</term><def><p id="Par18">Enterobacterial repetitive intergenic consensus</p></def></def-item><def-item><term>RT-LAMP</term><def><p id="Par19">Reverse Transcription Loop-Mediated Isothermal Amplification</p></def></def-item><def-item><term>AMOS-PCR</term><def><p id="Par20">Abortus melitensis ovis Suis polymerase chain reaction</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#8217;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>Thank you for the samples provided by the breeding sites and the strong support of the staff, and thank all the authors for their contribution to this article.</p></ack><notes notes-type="author-contribution"><title>Authors&#8217; contributions</title><p>WL and CX designed the research; XR conducted data analysis and wrote manuscripts and clinical sample detection. XR and ZL searched for differential sequences and designed primers and probes. Finally, the diagnostic method was established.YT was responsible for the detection of bacterial retention.YY were responsible for the detection of milk samples.WG instructed the writing.All authors read and approved the final manuscript. Note : XR, ZL, YT contributed equally to this work and are co-first authors of this manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This work was funded by the Inner Mongolia Autonomous Region First Class Discipline Research Special Project (YLXKZX-NND-012),the Key technologies of dairy goat germplasm innovation and intensive precision breeding(2021ZD0023) and the Comparative genomics study of <italic toggle="yes">Brucella</italic> virulent strains and vaccine strains and establishment of diagnostic methods(NJZZ19041).</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>The datasets supporting the results of this document are contained within the article. Any additional data may be requested to the corresponding author.</p></notes><notes><title>Declarations</title><notes id="FPar6"><title>Ethics approval and consent to participate</title><p id="Par76">The experimental animals used in this project were treated in strict accordance with the Guidelines for Animal Ethics and Experimentation of thePeople&#8217;s Republic of China. The experimental animals were used in accordance with the protocols approved by The Scientifc Ethics Committee of Inner Mongolia Agricultural University (Approval code: NND2022112).Before collecting samples, we have obtained the informed consent of the animal owner.</p></notes><notes id="FPar7"><title>Consent for publication</title><p id="Par77">Not applicable.</p></notes><notes id="FPar8" notes-type="COI-statement"><title>Competing interests</title><p id="Par78">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Celli</surname><given-names>J</given-names></name><name name-style="western"><surname>Gorvel</surname><given-names>JP</given-names></name></person-group><article-title>Organelle robbery: Brucella interactions with the endoplasmic reticulum</article-title><source>Curr Opin Microbiol</source><year>2004</year><volume>7</volume><issue>1</issue><fpage>93</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">15036147</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.mib.2003.11.001</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Celli J, Gorvel JP. Organelle robbery: Brucella interactions with the endoplasmic reticulum. Curr Opin Microbiol. 2004;7(1):93&#8211;7.<pub-id pub-id-type="pmid">15036147</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.mib.2003.11.001</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seleem</surname><given-names>MN</given-names></name><name name-style="western"><surname>Boyle</surname><given-names>SM</given-names></name><name name-style="western"><surname>Sriranganathan</surname><given-names>N</given-names></name></person-group><article-title>Brucella: a pathogen without classic virulence genes</article-title><source>Vet Microbiol</source><year>2008</year><volume>129</volume><issue>1&#8211;2</issue><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">18226477</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.vetmic.2007.11.023</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Seleem MN, Boyle SM, Sriranganathan N. Brucella: a pathogen without classic virulence genes. Vet Microbiol. 2008;129(1&#8211;2):1&#8211;14.<pub-id pub-id-type="pmid">18226477</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.vetmic.2007.11.023</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>MY</given-names></name></person-group><article-title>Research progress on epidemic status and detection methods of brucellosis in China</article-title><source>Chin Qighai J Anim Vet Sci</source><year>2024</year><volume>54</volume><issue>02</issue><fpage>56</fpage><lpage>59</lpage></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Gao MY. Research progress on epidemic status and detection methods of brucellosis in China. Chin Qighai J Anim Vet Sci. 2024;54(02):56&#8211;9 in Chinese.</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>WH</given-names></name></person-group><article-title>Research progress on laboratory diagnosis technology of animal Brucellosis</article-title><source>Shandong J Anim Sci Vet Med</source><year>2024</year><volume>45</volume><issue>09</issue><fpage>91</fpage><lpage>94</lpage></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Liu WH. Research progress on laboratory diagnosis technology of animal Brucellosis. Shandong J Anim Sci Vet Med. 2024;45(09):91&#8211;4 in Chinese.</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>HC</given-names></name><name name-style="western"><surname>Liu</surname><given-names>XY</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>LY</given-names></name></person-group><article-title>Advances in diagnostic techniques of brucellosis</article-title><source>China Anim Health.</source><year>2024</year><volume>26</volume><issue>03</issue><fpage>7</fpage><lpage>8</lpage></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Liu HC, Liu XY, Zhu LY. Advances in diagnostic techniques of brucellosis. China Anim Health. 2024;26(03):7&#8211;8 in Chinese.</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>von Bargen</surname><given-names>K</given-names></name><name name-style="western"><surname>Gorvel</surname><given-names>JP</given-names></name><name name-style="western"><surname>Salcedo</surname><given-names>SP</given-names></name></person-group><article-title>Internal affairs: investigating the Brucella intracellular lifestyle</article-title><source>FEMS Microbiol Rev</source><year>2012</year><volume>36</volume><issue>3</issue><fpage>533</fpage><lpage>562</lpage><pub-id pub-id-type="pmid">22373010</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1574-6976.2012.00334.x</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">von Bargen K, Gorvel JP, Salcedo SP. Internal affairs: investigating the Brucella intracellular lifestyle. FEMS Microbiol Rev. 2012;36(3):533&#8211;62.<pub-id pub-id-type="pmid">22373010</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1574-6976.2012.00334.x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hou</surname><given-names>H</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><name name-style="western"><surname>Peng</surname><given-names>Q</given-names></name></person-group><article-title>The advances in brucellosis vaccines</article-title><source>Vaccine</source><year>2019</year><volume>37</volume><issue>30</issue><fpage>3981</fpage><lpage>3988</lpage><pub-id pub-id-type="pmid">31176541</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.vaccine.2019.05.084</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Hou H, Liu X, Peng Q. The advances in brucellosis vaccines. Vaccine. 2019;37(30):3981&#8211;8.<pub-id pub-id-type="pmid">31176541</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.vaccine.2019.05.084</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>T</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>TY</given-names></name><name name-style="western"><surname>Li</surname><given-names>SY</given-names></name><name name-style="western"><surname>Wang</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>ZD</given-names></name><name name-style="western"><surname>Lin</surname><given-names>SJ</given-names></name></person-group><article-title>Research progress of digital PCR technology in pig disease detection</article-title><source>Heilongjiang Anim Sci Vet Med</source><year>2022</year><volume>24</volume><fpage>35</fpage><lpage>38+43</lpage></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Zheng T, Zhang TY, Li SY, Wang WJ, Zhang ZD, Lin SJ. Research progress of digital PCR technology in pig disease detection. Heilongjiang Anim Sci Vet Med. 2022;24:35&#8211;8+43 in Chinese.</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>ZA</given-names></name><name name-style="western"><surname>Nan</surname><given-names>WL</given-names></name><name name-style="western"><surname>Wu</surname><given-names>XD</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>JR</given-names></name><name name-style="western"><surname>Gao</surname><given-names>YN</given-names></name><etal/></person-group><article-title>Establishment and application of a TaqMan real-time PCR assay for detection of lumpy skin disease virus</article-title><source>Anim Husbandry Vet Med</source><year>2022</year><volume>54</volume><issue>11</issue><fpage>100</fpage><lpage>105</lpage></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Wu ZA, Nan WL, Wu XD, Wang Y, Wang JR, Gao YN, et al. Establishment and application of a TaqMan real-time PCR assay for detection of lumpy skin disease virus. Anim Husbandry Vet Med. 2022;54(11):100&#8211;5 in Chinese.</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>An</surname><given-names>LL</given-names></name><name name-style="western"><surname>Liu</surname><given-names>QY</given-names></name><name name-style="western"><surname>Lan</surname><given-names>QJ</given-names></name><name name-style="western"><surname>Luo</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>YQ</given-names></name></person-group><article-title>Establishment of a TaqMan real-time PCR assay for detection of pigeon adenovirus type I and analysis of its genetic evolution</article-title><source>Acta Agric Univ Jiangxiensis</source><year>2025</year><volume>47</volume><issue>01</issue><fpage>167</fpage><lpage>177</lpage></element-citation><mixed-citation id="mc-CR10" publication-type="journal">An LL, Liu QY, Lan QJ, Luo X, Zhao YQ. Establishment of a TaqMan real-time PCR assay for detection of pigeon adenovirus type I and analysis of its genetic evolution. Acta Agric Univ Jiangxiensis. 2025;47(01):167&#8211;77 in Chinese.</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xue</surname><given-names>Z</given-names></name><name name-style="western"><surname>You</surname><given-names>M</given-names></name><name name-style="western"><surname>Peng</surname><given-names>P</given-names></name><etal/></person-group><article-title>Taqman-MGB nanoPCR for highly specific detection of single-base mutations</article-title><source>Int J Nanomedicine</source><year>2021</year><volume>16</volume><fpage>3695</fpage><lpage>3705</lpage><pub-id pub-id-type="pmid">34113098</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/IJN.S310254</pub-id><pub-id pub-id-type="pmcid">PMC8185130</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Xue Z, You M, Peng P, et al. Taqman-MGB nanoPCR for highly specific detection of single-base mutations. Int J Nanomedicine. 2021;16:3695&#8211;705.<pub-id pub-id-type="pmid">34113098</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/IJN.S310254</pub-id><pub-id pub-id-type="pmcid">PMC8185130</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="other">Huang YL, LI SQ, Yin J, Gao L, Yang TJ, Xu M et al. Study on diagnosis and comprehensive prevention and control measures of brucellosis in cattle and sheep. Modern J Anim Husbandry Vet Med. 2024;01:75&#8211;80 (in Chinese).</mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="other">Me NQ, Zhang JL, Shi K, Wang H, Du Y.Epidemiological characteristics and diagnosis of brucellosis in sheep under immunological background. Heilongjiang Anim Sci Vet Med. 2020;05:4&#8211;8+14 (in Chinese).</mixed-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="other">Sun Y, Wang P, Liu Q, Zhao MJ, Zhu YH. Comparison of the application effects of four serological test methods in the detection of brucellosis in cattle and sheep. Contemp Anim Husbandry. 2024;06:54&#8211;6 (in Chinese).</mixed-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="other">Fan BJ, Song XS, Liang Q. Application of whole milk ring test in the detection of brucellosis in dairy cows .Chin J Vet Med. 2005;41(12):50&#8211;1 (in Chinese).</mixed-citation></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bricker</surname><given-names>BJ</given-names></name></person-group><article-title>PCR as a diagnostic tool for brucellosis</article-title><source>Vet Microbiol.</source><year>2002</year><volume>90</volume><issue>1&#8211;4</issue><fpage>435</fpage><lpage>446</lpage><pub-id pub-id-type="pmid">12414163</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0378-1135(02)00228-6</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Bricker BJ. PCR as a diagnostic tool for brucellosis. Vet Microbiol. 2002;90(1&#8211;4):435&#8211;46.<pub-id pub-id-type="pmid">12414163</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0378-1135(02)00228-6</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Notomi</surname><given-names>T</given-names></name><name name-style="western"><surname>Okayama</surname><given-names>H</given-names></name><name name-style="western"><surname>Masubuchi</surname><given-names>H</given-names></name><name name-style="western"><surname>Yonekawa</surname><given-names>T</given-names></name><name name-style="western"><surname>Watanabe</surname><given-names>K</given-names></name><name name-style="western"><surname>Amino</surname><given-names>N</given-names></name><name name-style="western"><surname>Hase</surname><given-names>T</given-names></name></person-group><article-title>Loop-mediated isothermal amplification of DNA</article-title><source>Nucleic Acids Res</source><year>2000</year><volume>28</volume><issue>12</issue><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">10871386</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/28.12.e63</pub-id><pub-id pub-id-type="pmcid">PMC102748</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, Hase T. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 2000;28(12):1&#8211;7.<pub-id pub-id-type="pmid">10871386</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/28.12.e63</pub-id><pub-id pub-id-type="pmcid">PMC102748</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="other">Mu JM. Establishment of LAMP method for differential detection of Brucella. Inner Mongolia Agricultural University. 2021.( in Chinese)</mixed-citation></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Atoui</surname><given-names>A</given-names></name><name name-style="western"><surname>El Khoury</surname><given-names>A</given-names></name></person-group><article-title>PCR-RFLP for Aspergillus Species</article-title><source>Methods Mol Biol</source><year>2017</year><volume>1542</volume><fpage>313</fpage><lpage>320</lpage><pub-id pub-id-type="pmid">27924547</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-1-4939-6707-0_20</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Atoui A, El Khoury A. PCR-RFLP for Aspergillus Species. Methods Mol Biol. 2017;1542:313&#8211;20.<pub-id pub-id-type="pmid">27924547</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-1-4939-6707-0_20</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>WL</given-names></name></person-group><article-title>Study on the differential diagnosis method of natural infection and vaccine immunization of brucellosis in dairy cows</article-title><source>Inner Mongolia Agric Univ</source><year>2021</year><volume>03</volume><issue>12</issue><fpage>1</fpage><lpage>11</lpage></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Wang WL. Study on the differential diagnosis method of natural infection and vaccine immunization of brucellosis in dairy cows. Inner Mongolia Agric Univ. 2021;03(12):1&#8211;11 (in Chinese).</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>XQ</given-names></name><name name-style="western"><surname>Hao</surname><given-names>M</given-names></name><name name-style="western"><surname>Lei</surname><given-names>ZH</given-names></name><name name-style="western"><surname>Yang</surname><given-names>D</given-names></name><name name-style="western"><surname>Hai</surname><given-names>XM</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><etal/></person-group><article-title>Establishment and preliminary evaluation of TaqMan real-time PCR detection method for Brucella</article-title><source>Int J Lab Med</source><year>2024</year><volume>45</volume><issue>11</issue><fpage>1399</fpage><lpage>1403</lpage></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Chang XQ, Hao M, Lei ZH, Yang D, Hai XM, Li J, et al. Establishment and preliminary evaluation of TaqMan real-time PCR detection method for Brucella. Int J Lab Med. 2024;45(11):1399&#8211;403 in Chinese.</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="other">Sun QL, Ma YY, Sun L, Fei DL, Bai JY, Zhang X el al. Establishment of TaqMan-MGB RT-PCR for detection of murine Sendai virus. Chin J Virol. 2023;39(01):144&#8211;52 in Chinese.</mixed-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="other">Zhang W, Shan KR, Wu CX, Li Y, Xiao Y, Qi XL et al. Feasibility study of TaqMan-MGB probe for detecting GSTP1 exon 5 SNP .Progress in Modern Biomedicine. 2006;6(12):24&#8211;6+30 (in Chinese).</mixed-citation></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Su&#225;rez-Esquivel</surname><given-names>M</given-names></name><name name-style="western"><surname>Chaves-Olarte</surname><given-names>E</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>E</given-names></name><name name-style="western"><surname>Guzm&#225;n-Verri</surname><given-names>C</given-names></name></person-group><article-title>Brucella genomics: macro and micro evolution</article-title><source>Int J Mol Sci</source><year>2020</year><volume>21</volume><issue>20</issue><fpage>7749</fpage><pub-id pub-id-type="pmid">33092044</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms21207749</pub-id><pub-id pub-id-type="pmcid">PMC7589603</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Su&#225;rez-Esquivel M, Chaves-Olarte E, Moreno E, Guzm&#225;n-Verri C. Brucella genomics: macro and micro evolution. Int J Mol Sci. 2020;21(20):7749.<pub-id pub-id-type="pmid">33092044</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms21207749</pub-id><pub-id pub-id-type="pmcid">PMC7589603</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feng</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Li</surname><given-names>KD</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Liu</surname><given-names>W</given-names></name></person-group><article-title>Laboratory diagnosis technology of brucellosis</article-title><source>Modern Agric Sci Technol</source><year>2024</year><volume>09</volume><fpage>94</fpage><lpage>95</lpage></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Feng GJ, Li KD, Zhang Z, Liu W. Laboratory diagnosis technology of brucellosis. Modern Agric Sci Technol. 2024;09:94&#8211;5 in Chinese.</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="other">Tan XZ. Research progress on epidemic status and diagnostic methods of brucellosis between human and livestock in China. Chin J Anim Infect Dis. 2024;32(5)213&#8211;21( in Chinese).</mixed-citation></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cui</surname><given-names>L</given-names></name><name name-style="western"><surname>Ma</surname><given-names>LZ</given-names></name></person-group><article-title>Comprehensive prevention and control and purification of sheep brucellosis</article-title><source>Xinjiang Xumuye</source><year>2024</year><volume>40</volume><issue>04</issue><fpage>37</fpage><lpage>40</lpage></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Cui L, Ma LZ. Comprehensive prevention and control and purification of sheep brucellosis. Xinjiang Xumuye. 2024;40(04):37&#8211;40 in Chinese.</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhuo</surname><given-names>XJ</given-names></name></person-group><article-title>Immune measures of bovine and sheep brucellosis and its application prospect</article-title><source>Anim Ind Environ</source><year>2024</year><volume>08</volume><fpage>70</fpage><lpage>72</lpage></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Zhuo XJ. Immune measures of bovine and sheep brucellosis and its application prospect. Anim Ind Environ. 2024;08:70&#8211;2 in Chinese.</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>ZQ</given-names></name><name name-style="western"><surname>Xing</surname><given-names>J</given-names></name><name name-style="western"><surname>Feng</surname><given-names>YF</given-names></name><name name-style="western"><surname>Yue</surname><given-names>BF</given-names></name><name name-style="western"><surname>He</surname><given-names>ZM</given-names></name></person-group><article-title>TaqMan MGB probe real-time PCR for rapid detection of Brucella</article-title><source>Chin J Zoonoses.</source><year>2011</year><volume>27</volume><issue>11</issue><fpage>995</fpage><lpage>1000</lpage></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Gao ZQ, Xing J, Feng YF, Yue BF, He ZM. TaqMan MGB probe real-time PCR for rapid detection of Brucella. Chin J Zoonoses. 2011;27(11):995&#8211;1000 in Chinese.</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>HW</given-names></name><name name-style="western"><surname>Xu</surname><given-names>L</given-names></name><name name-style="western"><surname>Fan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Bao</surname><given-names>GY</given-names></name><name name-style="western"><surname>Chen</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>TC</given-names></name></person-group><article-title>Study on the detection of Brucella nucleic acid in blood of patients with brucellosis based on droplet digital polymerase chain reaction technology</article-title><source>Dis Surveill</source><year>2024</year><volume>39</volume><issue>06</issue><fpage>751</fpage><lpage>755</lpage></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Liu HW, Xu L, Fan Y, Bao GY, Chen JJ, Zhang TC. Study on the detection of Brucella nucleic acid in blood of patients with brucellosis based on droplet digital polymerase chain reaction technology. Dis Surveill. 2024;39(06):751&#8211;5 in Chinese.</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saini</surname><given-names>S</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>VK</given-names></name><name name-style="western"><surname>Gururaj</surname><given-names>K</given-names></name><name name-style="western"><surname>Singh</surname><given-names>DD</given-names></name><name name-style="western"><surname>Pawaiya</surname><given-names>RVS</given-names></name><name name-style="western"><surname>Gangwar</surname><given-names>NK</given-names></name><name name-style="western"><surname>Mishra</surname><given-names>AK</given-names></name><name name-style="western"><surname>Dwivedi</surname><given-names>D</given-names></name><name name-style="western"><surname>Andani</surname><given-names>D</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>A</given-names></name><name name-style="western"><surname>Goswami</surname><given-names>TK</given-names></name></person-group><article-title>Comparative diagnostic evaluation of OMP31 gene based TaqMan&#174; real-time PCR assay with visual LAMP assay and indirect ELISA for caprine brucellosis</article-title><source>Trop Anim Health Prod</source><year>2017</year><volume>49</volume><issue>6</issue><fpage>1253</fpage><lpage>1264</lpage><pub-id pub-id-type="pmid">28638960</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11250-017-1323-7</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Saini S, Gupta VK, Gururaj K, Singh DD, Pawaiya RVS, Gangwar NK, Mishra AK, Dwivedi D, Andani D, Kumar A, Goswami TK. Comparative diagnostic evaluation of OMP31 gene based TaqMan&#174; real-time PCR assay with visual LAMP assay and indirect ELISA for caprine brucellosis. Trop Anim Health Prod. 2017;49(6):1253&#8211;64.<pub-id pub-id-type="pmid">28638960</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11250-017-1323-7</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nan</surname><given-names>W</given-names></name><name name-style="western"><surname>Tan</surname><given-names>P</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Mao</surname><given-names>K</given-names></name><name name-style="western"><surname>Peng</surname><given-names>D</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name></person-group><article-title>Duplex PCR for differentiation of the vaccine strain Brucella suis S2 and B. suis biovar 1 from other strains of Brucella spp</article-title><source>Vet J.</source><year>2014</year><volume>201</volume><issue>3</issue><fpage>427</fpage><lpage>428</lpage><pub-id pub-id-type="pmid">25011712</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tvjl.2014.05.033</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Nan W, Tan P, Wang Y, Xu Z, Mao K, Peng D, Chen Y. Duplex PCR for differentiation of the vaccine strain Brucella suis S2 and B. suis biovar 1 from other strains of Brucella spp. Vet J. 2014;201(3):427&#8211;8.<pub-id pub-id-type="pmid">25011712</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tvjl.2014.05.033</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article></pmc-articleset>